UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

______________________

FORM 10-Q

______________________

(Mark One)


x			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, ~~2022~~2023


o			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

______________________

Hyzon Motors Inc.

(Exact name of registrant as specified in its charter)

______________________


Delaware	001-39632	82-2726724
(State or other jurisdiction of incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)


475 Quaker Meeting House Road Honeoye Falls, NY			14472
(Address of principal executive offices)			(Zip Code)

(585)-484-9337

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

______________________

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading

Symbol(s)

Name of each exchange

on which registered

Common Stock, par value $0.0001 per share

HYZN

NASDAQ Capital Market

Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share

HYZNW

NASDAQ Capital Market

______________________

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ox No xo

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ox No xo

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the

Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x

As of ~~March~~October 31, 2023, ~~244,561,073~~there were approximately 245,002,825 shares of ~~Class A Common Stock,~~the registrant’s common stock outstanding, par value $0.0001 per share, ~~were issued and~~ outstanding.

Table of Contents

CAUTIONARY NOTE REGARDING ~~FORWARD- LOOKING~~FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These statements include, without limitation, statements regarding the financial position, business strategy and the plans and objectives of management for future operations, and any statements that refer to characterizations of future events or circumstances, including any underlying assumptions. These statements constitute projections, forecasts, and forward-looking statements, and are not guarantees of performance. Such statements can be identified by the fact that they do not relate strictly to historical or current facts. When used in this report, the words “could,” “should”, “will,” “may,” “anticipate,” “believe,” “expect,” “estimate,” “intend,” “plan,” “project,” the negative of such terms and other similar expressions are intended to identify forward looking statements, although not all forward-looking statements contain such identifying words. Such forward-looking statements are based on management’s current expectations and assumptions about future events and are based on currently available information as to the outcome and timing of future events.

Forward-looking statements are subject to a number of risks and uncertainties including, but not limited to, those described below and under the section entitled ~~“Risk Factors” included~~“Risk Factors” in our Annual Report filed on Form 10-K for the year ended December 31, ~~2021, as amended by Amendment No. 1 on Form 10-K/A filed with the Securities and Exchange Commission (“SEC”) on March 14, 2023,~~2022, and in subsequent reports that we file with the SEC, including this Form 10-Q for the quarter ended September 30, ~~2022:~~2023.

•we have incurred significant losses since our inception and expect to incur losses in the foreseeable future, and there is substantial doubt that we will have sufficient funds to satisfy our obligations through the next 12 months from the date of this report;

•our ability to continue as a going concern, which requires us to manage costs and obtain additional funding of our operations, including ramping up the production phase of our operations which includes beginning commercial scale production, launching the sale of our vehicles, and investing in research and development of additional products;

•our ability to raise financing in the future; if we are unable to obtain sufficient additional funding or do not have access to capital, we will be unable to execute our business plans and our prospects, financial condition and results of operations could be materially adversely affected;

•our corporate restructuring and the associated headcount reduction may not result in anticipated savings, which could result in total costs and expenses that are greater than expected and could disrupt our business;

•our ability to commercialize our products and strategic plans, including our ability to establish facilities to produce our fuel cells, assemble our vehicles or secure hydrogen supply in appropriate volumes, at competitive costs or with competitive emissions profiles;

•our ability to effectively compete in the heavy-duty transportation sector, and withstand intense competition and competitive pressures from other companies worldwide in the industries in which we operate;

•our ability to convert non-binding memoranda of understanding and ~~letters of intent~~vehicle trial agreements into binding orders or sales (including because of the current or prospective resources of our counterparties) and the ability of our counterparties to make payments on orders;

•our ability to invest in hydrogen production, distribution, and refueling operations to supply our customers with hydrogen at competitive costs to operate their fuel cell electric vehicles;

•our hydrogen-powered commercial vehicles and hydrogen fuel cell systems depend on the availability of hydrogen; there is no assurance that there will be, or that we will be able to supply, hydrogen at prices or with an emission profile that allow our FCEVs to be competitive with commercial vehicles powered by other energy sources, and our lack of control over or limited availability of hydrogen may adversely impact our sales and product deployment;

•disruptions to the global supply chain, including as a result of ~~the COVID-19 pandemic, the war in Ukraine and~~ geopolitical events, and ~~shortage~~shortages of raw materials, and the related impacts on our ~~third party~~third-party suppliers and assemblers;

•our ability to maintain the listing of our common stock on ~~NASDAQ;~~

•~~our ability to raise financing in~~ the ~~future;~~Nasdaq Capital Market;

•our ability to retain or recruit, or changes required in, our officers, key employees or directors;

•~~cybersecurity threats and breaches and compliance with privacy and data protection laws;~~

•our ability to protect, defend, or enforce our intellectual property on which we depend; and

•the impacts of legal proceedings, regulatory disputes, and governmental inquiries.

We have experienced and continue to experience several of these risks which have had and are having a materially negative effect on our results of operations. Should ~~one or more of the~~these risks increase, should risks or uncertainties other than those described above materialize, or should our underlying assumptions prove incorrect, our actual results and plans could differ materially from those expressed in any forward-looking statements.

The forward-looking statements contained in this report are based on our current expectations and beliefs concerning future developments and their potential effects on us, and speak only as of the date of this report. Except as otherwise required by applicable law, we disclaim any duty to update any ~~forward looking~~forward-looking statements, all of which are expressly qualified by the statements in this section, to reflect events or circumstances after the date of this report. You should, however, review additional disclosures we make in subsequent filings with the SEC.

Table of Contents

Hyzon Motors, Inc.

Quarterly Report on Form 10-Q

Table of Contents

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

HYZON MOTORS INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share amounts)

(unaudited)


		September 30, 2022		December 31, 2021			September 30, 2023		December 31, 2022
ASSETS	ASSETS					ASSETS
Current assets	Current assets					Current assets
Cash and cash equivalents	Cash and cash equivalents	$	70,602	$	445,146	Cash and cash equivalents	$	110,614	$	60,554
Short-term investments	Short-term investments	239,648		—		Short-term investments	27,193		194,775
Accounts receivable	Accounts receivable	48		2,956		Accounts receivable	297		29
Related party receivable	Related party receivable	64		264		Related party receivable	321		6,578
Inventory	Inventory	39,825		20,927		Inventory	41,233		35,553
Prepaid expenses and other current assets	Prepaid expenses and other current assets	24,070		26,852		Prepaid expenses and other current assets	11,510		15,365
Total current assets	Total current assets	374,257		496,145		Total current assets	191,168		312,854
Property, plant, and equipment, net	Property, plant, and equipment, net	24,869		14,346		Property, plant, and equipment, net	19,549		22,420
Right-of-use assets	Right-of-use assets	9,250		10,265		Right-of-use assets	5,082		9,181
Investments in equity securities	Investments in equity securities	15,030		4,948		Investments in equity securities	15,030		15,030
Equity method investment						Equity method investment	8,328		8,500
Other assets	Other assets	7,690		4,575		Other assets	6,056		6,911
Total Assets	Total Assets	$	431,096	$	530,279	Total Assets	$	245,213	$	374,896
LIABILITIES AND STOCKHOLDERS’ EQUITY	LIABILITIES AND STOCKHOLDERS’ EQUITY					LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities	Current liabilities					Current liabilities
Accounts payable	Accounts payable	$	8,033	$	7,980	Accounts payable	$	4,587	$	13,798
Accrued liabilities	Accrued liabilities	18,586		6,770		Accrued liabilities	22,893		25,587
Related party payables	Related party payables	399		3,695		Related party payables	443		433
Contract liabilities	Contract liabilities	784		10,925		Contract liabilities	7,737		3,919
Current portion of lease liabilities	Current portion of lease liabilities	2,212		1,886		Current portion of lease liabilities	1,896		2,132
Total current liabilities	Total current liabilities	30,014		31,256		Total current liabilities	37,556		45,869
Long term liabilities	Long term liabilities					Long term liabilities
Lease liabilities	Lease liabilities	7,585		8,830		Lease liabilities	6,071		7,492
Private placement warrant liability	Private placement warrant liability	1,843		15,228		Private placement warrant liability	561		1,122
Earnout liability	Earnout liability	16,390		103,761		Earnout liability	4,898		10,927
Deferred income taxes	Deferred income taxes	526		—		Deferred income taxes	526		526
Accrued SEC settlement						Accrued SEC settlement	16,500		—
Other liabilities	Other liabilities	5,774		1,139		Other liabilities	1,317		1,901
Total liabilities		62,132		160,214
Commitments and contingencies (Note 12)
Total Liabilities						Total Liabilities	$	67,429	$	67,837
Commitments and contingencies (Note 13)						Commitments and contingencies (Note 13)
Stockholders’ Equity	Stockholders’ Equity					Stockholders’ Equity
Common stock, $0.0001 par value; 400,000,000 shares authorized, 248,153,362 and 247,758,412 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively.		25		25
Common stock, $0.0001 par value; 400,000,000 shares authorized, 244,998,491 and 244,509,208 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively.						Common stock, $0.0001 par value; 400,000,000 shares authorized, 244,998,491 and 244,509,208 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively.	25		25
Treasury stock, at cost; 3,769,592 shares as of September 30, 2023 and December 31, 2022, respectively.						Treasury stock, at cost; 3,769,592 shares as of September 30, 2023 and December 31, 2022, respectively.	(6,446)		(6,446)
Additional paid-in capital	Additional paid-in capital	404,436		400,826		Additional paid-in capital	377,951		372,942
Accumulated deficit	Accumulated deficit	(15,731)		(26,412)		Accumulated deficit	(193,148)		(58,598)
Accumulated other comprehensive (loss) income		(300)		378
Accumulated other comprehensive income (loss)						Accumulated other comprehensive income (loss)	103		(153)
Total Hyzon Motors Inc. stockholders’ equity	Total Hyzon Motors Inc. stockholders’ equity	388,430		374,817		Total Hyzon Motors Inc. stockholders’ equity	178,485		307,770
Noncontrolling interest	Noncontrolling interest	(19,466)		(4,752)		Noncontrolling interest	(701)		(711)
Total Stockholders’ Equity	Total Stockholders’ Equity	368,964		370,065		Total Stockholders’ Equity	177,784		307,059
Total Liabilities and Stockholders’ Equity	Total Liabilities and Stockholders’ Equity	$	431,096	$	530,279	Total Liabilities and Stockholders’ Equity	$	245,213	$	374,896

The accompanying notes are an integral part of these unaudited consolidated financial statements.

Table of Contents

HYZON MOTORS INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

(in thousands, except per share amounts)

(unaudited)


		Three Months Ended September 30,				Nine Months Ended September 30,					Three Months Ended September 30,				Nine Months Ended September 30,
		2022		2021		2022		2021			2023		2022		2023		2022
Revenue	Revenue	$	5	$	89	$	2,939	$	89	Revenue	$	—	$	5	$	—	$	2,939
Operating expense:	Operating expense:									Operating expense:
Cost of revenue	Cost of revenue	8,203		204		10,226		204		Cost of revenue	3,286		8,203		6,534		10,226
Research and development	Research and development	9,241		3,982		26,660		8,081		Research and development	10,857		9,241		32,794		26,660
Selling, general, and administrative	Selling, general, and administrative	36,103		42,661		75,920		51,607		Selling, general, and administrative	21,044		36,103		100,999		75,920
Restructuring and asset impairment (Note 4)										Restructuring and asset impairment (Note 4)	4,885		—		4,885		—
Total operating expenses	Total operating expenses	53,547		46,847		112,806		59,892		Total operating expenses	40,072		53,547		145,212		112,806
Loss from operations	Loss from operations	(53,542)		(46,758)		(109,867)		(59,803)		Loss from operations	(40,072)		(53,542)		(145,212)		(109,867)
Other income (expense):	Other income (expense):									Other income (expense):
Change in fair value of private placement warrant liability	Change in fair value of private placement warrant liability	3,447		7,614		13,385		7,614		Change in fair value of private placement warrant liability	(240)		3,447		561		13,385
Change in fair value of earnout liability	Change in fair value of earnout liability	18,034		73,359		87,371		73,359		Change in fair value of earnout liability	(1,307)		18,034		6,029		87,371
Gain (loss) on equity securities	Gain (loss) on equity securities	—		—		10,082		—		Gain (loss) on equity securities	—		—		—		10,082
Foreign currency exchange loss and other income		(3,871)		(116)		(6,475)		(175)
Interest income (expense), net		279		(254)		350		(5,249)
Foreign currency exchange gain (loss) and other expense, net										Foreign currency exchange gain (loss) and other expense, net	(3,877)		(4,539)		(2,447)		(7,143)
Investment income and interest income, net										Investment income and interest income, net	1,441		947		6,501		1,018
Total other income (expense)	Total other income (expense)	17,889		80,603		104,713		75,549		Total other income (expense)	(3,983)		17,889		10,644		104,713
Net income (loss) before income taxes		(35,653)		33,845		(5,154)		15,746
Loss before income taxes										Loss before income taxes	$	(44,055)	$	(35,653)	$	(134,568)	$	(5,154)
Income tax expense	Income tax expense	—		—		526		—		Income tax expense	—		—		—		526
Net income (loss)		$	(35,653)	$	33,845	$	(5,680)	$	15,746
Net loss										Net loss	$	(44,055)	$	(35,653)	$	(134,568)	(5,680)
Less: Net loss attributable to noncontrolling interest	Less: Net loss attributable to noncontrolling interest	(10,858)		(776)		(16,361)		(1,307)		Less: Net loss attributable to noncontrolling interest	(1)		(10,858)		(18)		(16,361)
Net income (loss) attributable to Hyzon	Net income (loss) attributable to Hyzon	$	(24,795)	$	34,621	$	10,681	$	17,053	Net income (loss) attributable to Hyzon	$	(44,054)	$	(24,795)	$	(134,550)	$	10,681

Comprehensive income (loss):	Comprehensive income (loss):									Comprehensive income (loss):
Net income (loss)		$	(35,653)	$	33,845	$	(5,680)	$	15,746
Net loss										Net loss	$	(44,055)	$	(35,653)	$	(134,568)	$	(5,680)
Foreign currency translation adjustment	Foreign currency translation adjustment	862		(187)		838		(273)		Foreign currency translation adjustment	2,721		862		986		838
Unrealized gain on short-term investments		131		—		131		—
Comprehensive income (loss)		$	(34,660)	$	33,658	$	(4,711)	$	15,473
Less: Comprehensive loss attributable to noncontrolling interest		(9,705)		(749)		(14,714)		(1,269)
Net change in unrealized gain (loss) on short-term investments										Net change in unrealized gain (loss) on short-term investments	286		131		(702)		131
Comprehensive loss										Comprehensive loss	$	(41,048)	$	(34,660)	$	(134,284)	$	(4,711)
Less: Comprehensive income (loss) attributable to noncontrolling interest										Less: Comprehensive income (loss) attributable to noncontrolling interest	5		(9,705)		10		(14,714)
Comprehensive income (loss) attributable to Hyzon	Comprehensive income (loss) attributable to Hyzon	$	(24,955)	$	34,407	$	10,003	$	16,742	Comprehensive income (loss) attributable to Hyzon	$	(41,053)	$	(24,955)	$	(134,294)	$	10,003
Net income (loss) per share attributable to Hyzon:	Net income (loss) per share attributable to Hyzon:									Net income (loss) per share attributable to Hyzon:
Basic	Basic	$	(0.10)	$	0.15	$	0.04	$	0.09	Basic	$	(0.18)	$	(0.10)	$	(0.55)	$	0.04
Diluted	Diluted	$	(0.10)	$	0.14	$	0.04	$	0.08	Diluted	$	(0.18)	$	(0.10)	$	(0.55)	$	0.04
Weighted average common shares outstanding:	Weighted average common shares outstanding:									Weighted average common shares outstanding:
Basic	Basic	248,164		234,091		248,054		189,101		Basic	244,885		248,164		244,686		248,054
Diluted	Diluted	248,164		246,480		257,828		200,984		Diluted	244,885		248,164		244,686		257,828

The accompanying notes are an integral part of these unaudited consolidated financial statements.

Table of Contents

HYZON MOTORS INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

(in thousands, except share data)

(unaudited)

~~(unaudited)~~

Legacy
Common Stock Common Stock
Class A Additional
Paid-in
Capital Retained
Earnings
(Accumulated
Deficit) Accumulated
Other
Comprehensive
Income (Loss) Total Hyzon
Motors Inc.
Stockholders’
Equity (Deficit) Noncontrolling
Interest Total
Stockholders’
Equity (Deficit)
Shares Amount Shares Amount
Balance as of December 31, 2021 — $ — 247,758,412 $ 25 $ 400,826 $ (26,412) $ 378 $ 374,817 $ (4,752) $ 370,065
Exercise of stock options — — 35,324 — 40 — — 40 — 40
Stock-based compensation — — — — 3,052 — — 3,052 — 3,052
Vesting of RSUs — — 168,772 — — — — — — —
Net share settlement of equity awards — — — — (463) — — (463) — (463)
Common stock issued for the cashless exercise of warrants — — 44,349 — — — — — — —
Repurchase of warrants — — — — (31) — — (31) — (31)
Net income attributable to Hyzon — — — — — 35,476 — 35,476 — 35,476
Net loss attributable to noncontrolling interest — — — — — — — — (5,503) (5,503)
Foreign currency translation income (loss) — — — — — — (518) (518) 494 (24)
Balance as of June 30, 2022 — — 248,006,857 25 403,424 9,064 (140) 412,373 (9,761) 402,612
Exercise of stock options — — 3,544 — 4 — — 4 — 4
Stock-based compensation — — — — 1,063 — — 1,063 — 1,063
Vesting of RSUs — — 133,980 — — — — — — —
Net share settlement of equity awards — — — — (55) — — (55) — (55)
Common stock issued for the cashless exercise of warrants — — 8,981 — — — — — — —
Unrealized gain on short-term investments — — — — — — 131 131 — 131
Net loss attributable to Hyzon — — — — — (24,795) — (24,795) — (24,795)
Net loss attributable to noncontrolling interest — — — — — — — — (10,858) (10,858)
Foreign currency translation income (loss) — — — — — — (291) (291) 1,153 862
Balance as of September 30, 2022 — $ — 248,153,362 $ 25 $ 404,436 $ (15,731) $ (300) $ 388,430 $ (19,466) $ 368,964


	Common Stock Class A			Treasury Stock			Additional Paid-in Capital		Accumulated Deficit		Accumulated Other Comprehensive Loss		Total Hyzon Motors Inc. Stockholders’ Equity		Noncontrolling Interest		Total Stockholders’ Equity
	Shares	Amount		Shares	Amount
Balance as of December 31, 2022	244,509,208	$	25	3,769,592	$	(6,446)	$	372,942	$	(58,598)	$	(153)	$	307,770	$	(711)	$	307,059
Stock-based compensation	—	—		—	—		2,987		—		—		2,987		—		2,987
Vesting of RSUs	198,911	—		—	—		—		—		—		—		—		—
Net share settlement of equity awards	—	—		—	—		(111)		—		—		(111)		—		(111)
Available-for-sale short-term investments:
Unrealized net gain on short-term investments	—	—		—	—		—		—		616		616		—		616
Reclassification to net loss	—	—		—	—		—		—		(1,604)		(1,604)		—		(1,604)
Net loss attributable to Hyzon	—	—		—	—		—		(90,496)		—		(90,496)		—		(90,496)
Net loss attributable to noncontrolling interest	—	—		—	—		—		—		—		—		(17)		(17)
Foreign currency translation income (loss)	—	—		—	—		—		—		(1,757)		(1,757)		22		(1,735)
Balance as of June 30, 2023	244,708,119	$	25	3,769,592	$	(6,446)	$	375,818	$	(149,094)	$	(2,898)	$	217,405	$	(706)	$	216,699
Exercise of stock options	16,000	—		—	—		18		—		—		18		—		18
Stock-based compensation	—	—		—	—		2,156		—		—		2,156		—		2,156
Vesting of RSUs	274,372	—		—	—		—		—		—		—		—		—
Net share settlement of equity awards	—	—		—	—		(41)		—		—		(41)		—		(41)
Available-for-sale short-term investments:
Unrealized net gain on short-term investments	—	—		—	—		—		—		314		314		—		314
Reclassification to net loss	—	—		—	—		—		—		(28)		(28)		—		(28)
Net loss attributable to Hyzon	—	—		—	—		—		(44,054)		—		(44,054)		—		(44,054)
Net loss attributable to noncontrolling interest	—	—		—	—		—		—		—		—		(1)		(1)
Foreign currency translation income	—	—		—	—		—		—		2,715		2,715		6		2,721
Balance as of September 30, 2023	244,998,491	$	25	3,769,592	$	(6,446)	$	377,951	$	(193,148)	$	103	$	178,485	$	(701)	$	177,784

The accompanying notes are an integral part of these unaudited consolidated financial statements.

HYZON MOTORS INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

(in thousands, except share data)

(unaudited)


		Legacy Common Stock			Common Stock Class A			Additional Paid-in Capital				Retained Earnings (Accumulated Deficit)		Accumulated Other Comprehensive Loss				Total Hyzon Motors Inc. Stockholders’ Equity (Deficit)				Noncontrolling Interest			Total Stockholders’ Equity (Deficit)					Common Stock Class A						Treasury Stock			Additional Paid-in Capital				Retained Earnings (Accumulated Deficit)				Accumulated Other Comprehensive Income (Loss)				Total Hyzon Motors Inc. Stockholders’ Equity				Noncontrolling Interest				Total Stockholders’ Equity
		Shares	Amount		Shares	Amount														Shares							Amount				Shares				Amount
Balance as of December 31, 2020		93,750,000	$	94	—	$	—			$	29,045					$	(14,271)				$	(16)		$	14,852			$	(91)			$	14,761
Retroactive application of recapitalization		(93,750,000)	(94)		166,125,000	17		77				—		—				—				—			—
Adjusted balance, beginning of period		—	—		166,125,000	17		29,122				(14,271)		(16)				14,852				(91)			14,761
Balance as of December 31, 2021																											Balance as of December 31, 2021			247,758,412				$	25	—	$	—			$	400,826			$	(26,412)			$	378			$	374,817			$	(4,752)			$	370,065
Exercise of stock options	Exercise of stock options	—	—		132,900	—		190				—		—				190				—			190		Exercise of stock options			35,324				—		—	—		40				—				—				40				—				40
Stock-based compensation	Stock-based compensation	—	—		—	—		816				—		—				816				—			816		Stock-based compensation			—				—		—	—		3,052				—				—				3,052				—				3,052
IP transaction - deemed distribution		—	—		—	—		(10,000)				—		—				(10,000)				—			(10,000)
Net loss attributable to Hyzon		—	—		—	—		—				(17,568)		—				(17,568)				—			(17,568)
Net loss attributable to noncontrolling interest		—	—		—	—		—				—		—				—				(531)			(531)
Foreign currency translation income (loss)		—	—		—	—		—				—		(79)				(79)				11			(68)
Balance at June 30, 2021		—	—		166,257,900	17		20,128				(31,839)		(95)				(11,789)				(611)			(12,400)
Reverse recapitalization transaction, net		—	—		73,502,303	7		351,498				—		—				351,505				—			351,505
Issuance of common stock		—	—		7,234,006	1		(1)				—		—				—				—			—
Vesting of RSUs	Vesting of RSUs	—	—		284,796	—		—				—		—				—				—			—		Vesting of RSUs			168,772				—		—	—		—				—				—				—				—				—
Exercise of stock options		—	—		221,500	—		250				—		—				250				—			250
Stock-based compensation		—	—		—	—		28,146				—		—				28,146				—			28,146
Net share settlement of equity awards																											Net share settlement of equity awards			—				—		—	—		(463)				—				—				(463)				—				(463)
Common stock issued for the cashless exercise of warrants																											Common stock issued for the cashless exercise of warrants			44,349				—		—	—		—				—				—				—				—				—
Repurchase of warrants																											Repurchase of warrants			—				—		—	—		(31)				—				—				(31)				—				(31)
Net income attributable to Hyzon	Net income attributable to Hyzon	—	—		—	—		—				34,621		—				34,621				—			34,621		Net income attributable to Hyzon			—				—		—	—		—				35,476				—				35,476				—				35,476
Net loss attributable to noncontrolling interest	Net loss attributable to noncontrolling interest	—	—		—	—		—				—		—				—				(776)			(776)		Net loss attributable to noncontrolling interest			—				—		—	—		—				—				—				—				(5,503)				(5,503)
Foreign currency translation income (loss)	Foreign currency translation income (loss)	—	—		—	—		—				—		(232)				(232)				27			(205)		Foreign currency translation income (loss)			—				—		—	—		—				—				(518)				(518)				494				(24)
Balance as of September 30, 2021		—	$	—	247,500,505	$	25	$	400,021			$	2,782	$	(327)			$	402,501			$	(1,360)		$	401,141
Balance as of June 30, 2022																											Balance as of June 30, 2022			248,006,857				$	25	—	$	—	$	403,424			$	9,064			$	(140)			$	412,373			$	(9,761)			$	402,612
Exercise of stock options																											Exercise of stock options			3,544				—		—	—		4				—				—				4				—				4
Stock-based compensation																											Stock-based compensation			—				—		—	—		1,063				—				—				1,063				—				1,063
Vesting of RSUs																											Vesting of RSUs			133,980				—		—	—		—				—				—				—				—				—
Net share settlement of equity awards																											Net share settlement of equity awards			—				—		—	—		(55)				—				—				(55)				—				(55)
Common stock issued for the cashless exercise of warrants																											Common stock issued for the cashless exercise of warrants			8,981				—		—	—		—				—				—				—				—				—
Unrealized gain on short-term investments																											Unrealized gain on short-term investments			—				—		—	—		—				—				131				131				—				131
Net income attributable to Hyzon																											Net income attributable to Hyzon			—				—		—	—		—				(24,795)				—				(24,795)				—				(24,795)
Net loss attributable to noncontrolling interest																											Net loss attributable to noncontrolling interest			—				—		—	—		—				—				—				—				(10,858)				(10,858)
Foreign currency translation income (loss)																											Foreign currency translation income (loss)			—				—		—	—		—				—				(291)				(291)				1,153				862
Balance as of September 30, 2022																											Balance as of September 30, 2022			248,153,362				$	25	—	$	—	$	404,436			$	(15,731)			$	(300)			$	388,430			$	(19,466)			$	368,964

The accompanying notes are an integral part of these unaudited consolidated financial statements.

Table of Contents

HYZON MOTORS INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(unaudited)

Nine Months Ended
September 30,
2022 2021
Cash Flows from Operating Activities:
Net income (loss) $ (5,680) $ 15,746
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization 2,445 671
Stock-based compensation 4,115 29,023
Loss on extinguishment of convertible notes — 107
Deferred income tax expense 526 —
Accretion of discount on available-for-sale securities (185) —
Noncash interest expense — 5,449
Fair value adjustment of private placement warrant liability (13,385) (7,614)
Fair value adjustment of earnout liability (87,371) (73,359)
(Gain) loss on equity securities (10,082) —
Equity method investment loss 72 —
Changes in operating assets and liabilities:
Accounts receivable 2,676 (5,712)
Inventory (16,776) (12,008)
Prepaid expenses and other current assets 1,621 (19,638)
Other assets (383) (150)
Accounts payable 289 3,371
Accrued liabilities 11,678 3,082
Related party payables, net 31 3,821
Contract liabilities (5,053) 4,845
Other liabilities (756) 124
Net cash used in operating activities (116,218) (52,242)
Cash Flows from Investing Activities:
Purchases of property and equipment (11,320) (8,810)
Advanced payments for capital expenditures — (3,999)
Purchases of short-term investments (313,032) —
Proceeds from maturities of short-term investments 73,700 —
Investment in equity securities — (4,826)
Net cash used in investing activities (250,652) (17,635)
Cash Flows from Financing Activities:
Proceeds from Business Combination, net of redemption and transaction costs — 508,993
Exercise of stock options 44 440
Payment of finance lease liability (294) (135)
Debt issuance costs — (133)
Proceeds from issuance of convertible notes — 45,000
Net share settlement of equity awards
(517) —
Payment under Horizon IP agreement (3,146) —
Repurchase of warrants (31) —
Net cash (used in) provided by financing activities (3,944) 554,165
Effect of exchange rate changes on cash (967) — (853)
Net change in cash, cash equivalents, and restricted cash (371,781) 483,435
Cash, cash equivalents, and restricted cash — Beginning 449,365 17,139
Cash, cash equivalents, and restricted cash — Ending $ 77,584 $ 500,574
Supplemental schedule of non-cash investing activities and financing activities:
Lease assets obtained in exchange for lease obligations:
Operating leases — 6,803
Finance leases — —
Conversion of Legacy Hyzon common stock — 73
Recognition of earnout liability in Business Combination — 188,373
Recognition of private placement warrant liability in Business Combination — 19,395
Horizon license agreement payable — 10,000
Conversion of convertible notes for common stock — 50,198


	Nine Months Ended September 30,
	2023		2022
Cash Flows from Operating Activities:
Net income (loss)	$	(134,568)	$	(5,680)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	3,160		2,445
Stock-based compensation	5,143		4,115
Deferred income tax expense	—		526

Fair value adjustment of private placement warrant liability	(561)		(13,385)
Fair value adjustment of earnout liability	(6,029)		(87,371)
Fair value adjustment of value in equity securities	—		(10,082)
Accretion of discount on available-for-sale debt securities	(1,452)		(185)
Write-down of inventory	4,781		—
Loss on equity method investment	172		72
Foreign currency transaction loss	2,087		—
Write-down of property and equipment	2,119		—
Restructuring and asset impairment charges	4,885		—

Changes in operating assets and liabilities:
Accounts receivable	(264)		2,676
Inventory	(9,411)		(16,776)
Prepaid expenses and other current assets	4,087		1,621
Other assets	343		(383)
Accounts payable	(9,176)		289
Accrued liabilities	(2,763)		11,678
Related party payables, net	6,023		31
Contract liabilities	3,089		(5,053)
Other liabilities	16,263		(756)
Net cash used in operating activities	(112,072)		(116,218)
Cash Flows from Investing Activities:
Purchases of property and equipment	(5,951)		(11,320)

Purchases of short-term investments	(16,594)		(313,032)
Proceeds from sale of short-term investments	50,021		—
Proceeds from maturities of short-term investments	134,905		73,700

Net cash provided by (used in) investing activities	162,381		(250,652)
Cash Flows from Financing Activities:
Exercise of stock options	18		44
Payment of finance lease liability	(237)		(294)


Net share settlement of equity awards	(152)		(517)
Payment for purchase of Horizon IP	—		(3,146)
Repurchase of warrants	—		(31)
Net cash used in financing activities	(371)		(3,944)
Effect of exchange rate changes on cash	(377)		(967)
Net change in cash, cash equivalents, and restricted cash	49,561		(371,781)
Cash, cash equivalents, and restricted cash — Beginning	66,790		449,365
Cash, cash equivalents, and restricted cash — Ending	$	116,351	$	77,584

The accompanying notes are an integral part of these unaudited consolidated financial statements.

Table of Contents

HYZON MOTORS INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 1. Nature of Business and Basis of Presentation

Description of Business

Hyzon Motors Inc. (“Hyzon” or the “Company”), headquartered in Honeoye Falls, New York, is commercializing its proprietary heavy-duty (“HD”) fuel cell technology through ~~manufacturing~~assembling and ~~retrofitting heavy-duty~~upfitting HD hydrogen fuel cell electric vehicles (“FCEVs”) in the United States, Europe, and Australia. In addition, Hyzon ~~builds~~seeks to build and ~~fosters~~foster a clean hydrogen supply ecosystem with leading partners from feedstocks through production, dispensing, and financing. The Company is majority-owned by Hymas Pte. Ltd. (“Hymas”), a Singapore company, which is majority-owned but indirectly controlled by Horizon Fuel Cell Technologies PTE Ltd., a Singapore company (“Horizon”).

~~Business Combination and~~ Basis of Presentation

The accompanying unaudited interim consolidated financial statements and related disclosures have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) pursuant to the requirements and rules of the ~~SEC regarding interim reporting.~~Securities and Exchange Commission (“SEC”). Any reference in these notes to applicable guidance refers to U.S. GAAP as found in U.S. Accounting Standards Codification ("ASC") and Accounting Standards Update ("ASU") of the Financial Accounting Standards Board ("FASB"). Certain notes or other information that are normally required by U.S. GAAP have been omitted if they substantially duplicate the disclosures contained in the Company’s annual audited consolidated financial statements. Accordingly, the unaudited interim consolidated financial statements should be read in connection with the Company’s audited consolidated financial statements and related notes included in the Company’s ~~amended~~ Annual Report filed on Form ~~10-K/A~~10-K for the year ended December 31, ~~2021.~~2022.

The Company’s unaudited interim consolidated financial statements include the accounts and operations of the Company and its wholly owned subsidiaries including variable interest entity arrangements in which the Company is the primary beneficiary. All intercompany accounts and transactions are eliminated in consolidation. In the opinion of management, the accompanying unaudited interim consolidated financial statements include all normal and recurring adjustments necessary for a fair presentation for the periods presented. Results of operations reported for interim periods presented are not necessarily indicative of results for the entire year or any other periods.

~~On July 16, 2021 (the “Closing Date”), legacy Hyzon Motors Inc.~~Liquidity and now named Hyzon Motors USA Inc., (“Legacy Hyzon”), consummated the transactions contemplated by the Business Combination Agreement and Plan of Reorganization (the “Business Combination”), dated February 8, 2021, with Decarbonization Plus Acquisition Corporation (“DCRB”) to effect a business combination between DCRB and Legacy Hyzon with DCRB Merger Sub Inc., a wholly owned subsidiary of DCRB, merging with and into Legacy Hyzon, with Legacy Hyzon surviving the merger as a wholly owned subsidiary of DCRB. On the Closing Date, DCRB changed its name to “Hyzon Motors Inc.” and Legacy Hyzon changed its name to “Hyzon Motors USA Inc.”

The Business Combination was accounted for as a reverse recapitalization in accordance with U.S. GAAP, with no goodwill or other intangible assets recorded and the net assets of Legacy Hyzon consolidated with DCRB at historical cost. Under this method of accounting, DCRB is treated as the “acquired” company for financial reporting purposes.

Accordingly, the equity structure has been retrospectively adjusted in all comparative periods up to the Closing Date, to reflect the number of shares of the Company's common stock, $0.0001 par value per share issued to Legacy Hyzon's stockholders in connection with the reverse recapitalization. As such, the shares and corresponding capital amounts and earnings per share related to Legacy Hyzon common stock prior to the Business Combination have been retroactively restated as shares reflecting an exchange ratio of 1.772 (the “Exchange Ratio”).

~~Liquidity~~

The Company incurred net losses of $35.7 million and $5.7 million for the three and nine months ended September 30, 2022, respectively. The Company generated net income of $33.8 million and $15.7 million for the three and nine months ended September 30, 2021, respectively. Accumulated deficit amounted to $15.7 million and $26.4 million as of September 30, 2022 and December 31, 2021, respectively. Net cash used in operating activities was $116.2 million and $52.2 million for the nine months ended September 30, 2022 and 2021, respectively.

~~Table of Contents~~

On July 16, 2021, the Company received $509.0 million in cash, net of redemption and transaction costs as a result of the Business Combination. As of September 30, 2022, the Company has $70.6 million in unrestricted cash and cash equivalents, $239.6 million in short-term investments and $7.0 million in restricted cash. Restricted cash is pledged as security for letters of credit or other collateral amounts established by the Company for certain lease obligations, corporate credit cards, and other contractual arrangements. The Company’s restricted cash is included within Other assets in the unaudited interim Consolidated Balance Sheets.

As an early stage growth company, the Company expects to continue to incur net losses in the near term. As the Company commenced its internal restructuring effort in 2022, the primary focuses are the advancement of its proprietary fuel cell technology and development and commercialization of single heavy duty commercial vehicle platform in each region by leveraging third party contracted manufacturers. Until the Company can generate sufficient revenue from product sales, retrofit services or lease arrangements to cover operating expenses, working capital and capital expenditures, the Company will need to raise additional capital. The Company expects to fund cash needs through a combination of equity and debt financing, including lease securitization, strategic collaborations, and licensing arrangements. If the Company cannot raise additional funds when needed, our financial condition, business, prospects, and results of operations could be materially adversely affected.Going Concern

These unaudited interim consolidated financial statements have been prepared by management in accordance with U.S. GAAP and this basis assumes that the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. These unaudited interim consolidated financial statements do not include any adjustments that may result from the outcome of ~~this uncertainty. As~~the uncertainties described below.

In accordance with ASC 205-40, Presentation of Financial Statements - Going Concern (“ASC 205-40”), the Company evaluates whether there are certain conditions and events, considered in the aggregate, which raise substantial doubt about the Company’s ability to continue as a going concern. In accordance with ASC 205-40, the Company’s analysis can only include the potential mitigating impact of the ~~date~~plans that have not been fully implemented as of ~~this Quarterly Report on Form 10-Q, management believes that the Company’s existing financial resources will be sufficient to execute its operating priorities for the next 12 months following~~ the issuance date of these unaudited interim consolidated financial ~~statements.~~statements if (a) it is probable that these plans will be effectively implemented within one year after the date that the financial statements are issued, and (b) it is probable that the plans, when implemented, will alleviate the relevant conditions or events that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the financial statements are issued.

The Company incurred net losses of $44.1 million and $134.6 million for the three and nine months ended September 30, 2023, respectively. The Company incurred net losses of $35.7 million and $5.7 million for the three and nine months ended September 30, 2022, respectively. Accumulated deficit amounted to $193.1 million and $58.6 million as of September 30, 2023 and December 31, 2022, respectively. Net cash used in operating activities was $112.1 million and $116.2 million for the nine months ended September 30, 2023 and 2022, respectively. As of ~~March~~September 30, 2023, the Company has $110.6 million in unrestricted cash and cash equivalents, $27.2 million in short-term investments, and $5.7 million in restricted cash.

The Company has concluded that at the time of the filing, substantial doubt exists about its ability to continue as a going concern as the Company believes that its financial resources, existing cash resources and additional sources of liquidity are not sufficient to support planned operations beyond the next 12 months.

In order to reduce the cash used in operating activities, the Company implemented certain cost savings initiatives in late 2022 and the first half of 2023, as well as a restructuring plan in July 2023, as further discussed in Note 4. Restructuring and Related Charges. While these plans are anticipated to reduce cash outflows when compared to prior periods, the Company’s continued existence is dependent upon its ability to obtain additional financing, as well as to attain and maintain profitable operations by entering into profitable sales or service contracts and generating sufficient cash flow to meet its obligations on a timely basis. The Company’s business will require significant funding to execute its long-term business plans. As of October 31, 2023, unrestricted cash, cash equivalents, and short-term investments were approximately ~~$210~~$129 million.

~~Risks~~The Company plans to improve its liquidity through a combination of equity and/or debt financing, alliances or other partnership agreements with entities interested in our technologies, and ~~Uncertainties~~the liquidation of certain inventory balances. If the Company raises funds in the future by issuing equity securities, dilution to stockholders will occur and may be substantial. Any equity securities issued may also provide for rights, preferences, or privileges senior to those of common stockholders. If the Company raises funds in the future by issuing debt securities, these debt securities could have rights, preferences, and privileges senior to those of common stockholders. The terms of any debt securities or borrowings could impose significant restrictions on the Company’s operations. The capital markets have experienced in the past, and may experience in the future, periods of upheaval that could impact the availability and cost of equity and debt financing. In addition, recent and anticipated future increases in federal fund rates set by the Federal Reserve, which serve as a benchmark for rates on borrowing, will continue to impact the cost of debt financing.

~~The~~There can be no assurance that any such financing can be realized by the Company, or if realized, what the terms thereof may be, or that any amount that the Company is able to raise will be adequate to support the Company’s working capital requirements and/or fuel cell technology advancement. If the Company cannot raise additional funds when needed or on acceptable terms, the financial condition, business prospects, and results of operations could be materially adversely affected. In addition, the Company is subject to, and may become a party to, a variety of ~~risks~~litigation, other claims, suits, indemnity demands, regulatory actions, and ~~uncertainties common to early-stage companies with a history~~government investigations and inquiries in the ordinary course of ~~losses~~business. The outcome of litigation and other legal proceedings, including the other claims described under Legal Proceedings in Note 13. Commitments and Contingencies, are ~~expected to incur significant expenses~~inherently uncertain, and ~~continuing losses for the foreseeable future. The risks and uncertainties include, but~~adverse judgments or settlements in some or all of these legal disputes may result in materially adverse monetary damages or injunctive relief against us, which may not ~~limited to, further development of its technology, marketing and distribution channels, further development of its supply chain and manufacturing, development~~be covered in full or in part by ~~competitors of new technological innovations, dependence on key personnel, protection of proprietary technology, and the ability to secure additional capital to fund operations.~~insurance.

Reclassifications

Certain items previously reported in specific financial statement captions have been reclassified to conform to the current presentation in the unaudited interim consolidated financial statements and the accompanying notes.

~~Material Transactions~~

~~Orten Business Combination Cancellation~~Hyliion Inc. Technology Development Agreement

In ~~June 2022,~~February 2023, the Company entered into ~~an agreement~~a Technology Development Agreement (“TD Agreement”) with Hyliion Inc. for the purpose of working collaboratively to integrate a Hyzon fuel cell into a Hyliion powertrain on a Class 8 semi-truck. Subject to the terms and conditions of the TD Agreement, the parties grant one another a worldwide, irrevocable, nonexclusive, royalty-free, non-sublicensable license to their respective intellectual property solely for the limited purpose of developing the deliverable. The TD Agreement contains various representations, warranties, covenants, indemnities and other provisions customary for transactions of this nature. The term of the TD Agreement is one year, with the ~~intention~~option of ~~acquiring 100% of outstanding ownership in Orten Betriebs GmbH~~extending the term by mutual agreement. The Company agrees to reimburse Hyliion up to $1 million for research and ~~subsidiaries,~~development expenses incurred. During the three and ~~Orten Electric Trucks GmbH (collectively “Orten”). Subsequently, in~~nine months ended September ~~2022,~~30, 2023, the Company ~~terminated~~has incurred $0.3 million and $1.0 million of expenses under the agreement. As a result of the termination, the Company transferred consideration of €8.5 million (approximately $8.4 million in USD) to Orten consisting of €6.1 million (approximately $6.1 million in USD) in cashTD Agreement which have been recorded within Research and ~~€2.4 million (approximately $2.3 million in USD) in vehicle inventory. The amount of consideration transferred is included within Selling, general and administrative~~development expense in the unaudited interim Consolidated Statements of Operations and Comprehensive Income (Loss).

Table of Contents

Note 2. Summary of Significant Accounting Policies

The Company’s significant accounting policies are described in Note 3.2. Summary of Significant Accounting Policies, in the Company’s consolidated financial statements included in the Company’s ~~amended~~ Annual Report filed on Form ~~10-K/A~~10-K for the year ended December 31, ~~2021.~~2022.

~~Except for the policies noted below, there~~There have been no material changes to the significant accounting policies for the nine months ended September 30, ~~2022.~~2023.

~~Cash Equivalents~~

The Company’s cash equivalents consist of short-term, highly liquid financial instruments that are readily convertible to cash with original maturities of three months or less. Due to their short-term nature, the amortized cost of the Company’s cash equivalents approximate fair value. As of September 30, 2022, cash equivalents consisted of commercial paper, certificates of deposit and money market funds totaling $40.6 million. The Company did not have any cash equivalents as of December 31, 2021.

~~Short-term Investments~~

The Company has short-term investments in marketable debt securities with an original maturity of greater than three months, but less than one year. These securities include certificates of deposit, commercial paper, corporate debt, foreign government bonds, and U.S. Treasury bills. The Company may sell these marketable debt securities prior to their stated maturities depending upon changing liquidity requirements. The Company’s marketable debt securities have been classified and accounted for as available-for-sale (“AFS”) marketable securities in accordance with ASC 326, ~~Financial Instruments - Credit Losses~~. AFS securities are recorded at fair value as of each balance sheet date, with unrealized gains or losses included in Accumulated other comprehensive income (loss) and as a component of the Consolidated Statements of Operations and Comprehensive Income (Loss). Gains and losses as a result of sales or maturity of securities are reclassified from previously unrealized gains and losses on short-term investments in Accumulated other comprehensive income (loss) to Other income (expense), net in the Consolidated Statements of Operations and Comprehensive Income (Loss).

For an AFS security with an amortized cost that exceeds its fair value, the Company first determines if it intends to sell or will more-likely-than-not be required to sell the security before the expected recovery of its amortized cost. If it intends to sell or will more-likely-than-not be required to sell the security, then the Company recognizes the impairment as a credit loss in the Consolidated Statements of Operations and Comprehensive Income (Loss) by writing down the security’s amortized cost to its fair value. If it does not intend to sell or it is not more-likely-than-not that it will be required to sell the security before the expected recovery of its amortized cost, the Company recognizes the portion of the impairment that is due to a credit loss, if any, in the Consolidated Statements of Operations and Comprehensive Income (Loss) through an allowance. The portion of the impairment that is due to factors other than a credit loss is recognized in Comprehensive income (loss) in the Consolidated Statements of Operations and Comprehensive Income (Loss) as an unrealized loss. Accrued interest receivable is excluded from the estimate of credit losses (see Note 9. Short-term Investments).

~~Table of Contents~~

Note 3. Revenue

The Company did not recognize revenue for the three and nine months ended September 30, 2023. The Company recognized negligible revenue and $2.9 million in sales of hydrogen fuel cell systems in the United States, ~~and~~ sales of FCEVs in China, and ~~retrofit~~upfit services in Europe for the three and nine months ended September 30, 2022, respectively. ~~The Company recognized revenue of $0.1 million for the three and nine months ended September 30, 2021.~~

In accordance with ASC 606,Revenue from Contracts with Customers ("ASC 606"), the Company is required to evaluate customers’ ability and intent to pay substantially all of the consideration to which the Company is entitled in exchange for the vehicles transferred to the customer, i.e., collectability of contracts with customers. The Company’s two customers in China are special purpose entities established in response to China’s national hydrogen fuel cell vehicle pilot program. ~~While in the Company’s estimation the customers have strong business plans and management teams, in~~In consideration of the customers’ limited operating history and extended payment terms in their contracts, the Company determined the collectability criterion is not met with respect to contract existence under ASC 606 for ~~either customer,~~these customers, and therefore, an alternative method of revenue recognition has been applied to each arrangement.

The $2.5 million of revenue recognized from sales of FCEVs in China related to the delivery of 62 ~~FCEVS~~FCEVs in the nine months ended September 30, 2022. This amount is equal to the remaining consideration received after satisfying local government VAT obligations, as such amounts are non-refundable and the Company has transferred control of the 62 FCEVs to which the consideration relates and has stopped transferring goods or services to the customer. During the three months ended September 30, 2022, the Company delivered 20 additional FCEVs to a different customer, however, no amounts were recognized as revenue as the consideration received was less than the amounts paid to satisfy local government VAT obligations. The Company will continue to monitor the ~~customers~~customer and evaluate the collectability criterion as of each reporting period. The total cost of the 62 FCEVs delivered was recorded within Cost of revenue in the Consolidated Statements of Operations and Comprehensive ~~Loss~~Income (Loss) in 2021 since control of such FCEVs was transferred to the customer prior to December 31, 2021. The total cost of $2.9 million related to the additional 20 FCEVs was recorded within Cost of revenue in the unaudited interim Consolidated Statements of Operations and Comprehensive Income (Loss) during the three months ended September 30, 2022 since control of such FCEVs was transferred at the time of delivery.

Contract Balances

Contract liabilities relate to the advance consideration invoiced or received from customers for products and services prior to satisfying a performance obligation or in excess of amounts allocated to a previously satisfied performance obligation.

The current portion of contract liabilities is recorded within Contract liabilities in the unaudited interim Consolidated Balance Sheets and totaled ~~$0.8~~$7.7 million and ~~$10.9~~$3.9 million as of September 30, ~~2022~~2023 and December 31, ~~2021,~~2022, respectively. The long-term portion of contract liabilities is recorded within Other liabilities in the unaudited interim Consolidated Balance Sheets and totaled ~~$5.6~~$1.3 million and ~~$1.0~~$1.9 million as of September 30, ~~2022~~2023 and December 31, ~~2021,~~2022, respectively. ~~As part of efforts to exit certain customer contracts, the Company refunded $0.1 million in the fourth quarter of 2022.~~

Remaining Performance Obligations

The transaction price associated with remaining performance obligations for commercial vehicles and other contracts with customers was ~~$15.4~~$15.0 million as of September 30, ~~2022.~~2023. The Company expects to recognize ~~approximately 5%~~substantially all of its remaining performance obligations as revenue over the twelve months after September 30, ~~2022.~~2023.

Table of Contents

Note 4. Restructuring and Related Charges

Restructuring costs consist of employee-related charges that may include retention, relocation, severance, and other termination benefits, as well as, contract termination costs, accelerated depreciation, professional fees, and certain long-lived asset impairments. For ongoing benefit arrangements, a liability is recognized when it is probable that employees will be entitled to benefits and the amount can be reasonably estimated. For one-time benefit arrangements, a liability is incurred and accrued at the date the plan is communicated to employees, unless employees will be retained beyond a minimum retention period. In this case, the liability is calculated at the date the plan is communicated to employees and is accrued ratably over the future service period.

Restructuring costs including certain asset impairment are recorded in Restructuring and asset impairment in the unaudited interim Consolidated Statements of Operations and Comprehensive Income (Loss) as a component of loss from operations. Restructuring related liabilities are recorded within Accrued liabilities on the unaudited interim Consolidated Balance Sheets.

In July 2023, the Company’s board of directors approved a restructuring plan (the “Restructuring Program”) to improve operational effectiveness and cost reduction, including its workforce. Pursuant to the Restructuring Program, the Company expects to rationalize its global footprint, implement a shared service model for procurement and engineering, and transition to a third-party assembly model for FCEV upfit services. The Restructuring Program is expected to be completed by the end of third quarter of 2024.

The Company expects to incur employee-related charges such as one-time severance payments as well as cash bonus and stock-based compensation to drive retention through 2024. The Company anticipates modifying the affected employees’ stock awards in a manner that would result in additional non-cash charges.

As a result of the Restructuring Program, the Company evaluated long-lived assets for impairment at Hyzon Motors Europe B.V. (“Hyzon Europe”). The Company compared the carrying amount of the asset group comprising the long-lived assets to the estimated future undiscounted cash flows expected to be generated by the asset group. The estimated aggregate undiscounted cash flows were less than the carrying amount of the asset group. An impairment charge of $4.6 million ($2.8 million of right-of-use asset and $1.8 million of property, plant and equipment, net) was recorded during the third quarter of 2023, which represents the amount by which the carrying amount of the asset group exceeds the fair value of the assets, based on the expected discounted future cash flows attributable to those assets.

Costs by type associated with the Restructuring Program consisted of the following (in thousands):


	Three Months Ended September 30, 2023		Nine Months Ended September 30, 2023
Asset-related	$	4,602	$	4,602
Employee-related	283		283

Total	$	4,885	$	4,885

Table of Contents

Note 5. Inventory

Inventory consisted of the following (in thousands):


		September 30, 2022		December 31, 2021			September 30, 2023		December 31, 2022
Raw materials	Raw materials	$	26,434	$	16,099	Raw materials	$	24,574	$	24,862
Work in process	Work in process	13,391		4,828		Work in process	15,178		10,691
Finished Goods						Finished Goods	1,481		—
Total inventory	Total inventory	$	39,825	$	20,927	Total inventory	$	41,233	$	35,553

The Company writes down inventory for any excess or obsolescence, or when the Company believes that the net realizable value of inventories is less than the carrying value. ~~Inventory~~A total of $2.7 million and $4.8 million in inventory write-downs was recognized ~~in Cost~~for the three and nine months ended September 30, 2023, respectively. A total of ~~revenue were~~ $2.3 million and $3.0 million in inventory write-downs was recognized for the three and nine months ended September 30, 2022, respectively. The Company ~~did not write down any~~recorded the inventory ~~for~~write-downs in Cost of revenue in the ~~three~~unaudited interim Consolidated Statements of Operations and ~~nine months ended September 30, 2021, respectively.~~

~~Table of Contents~~

Comprehensive Income (Loss).

Note 5.6. Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):


		September 30, 2022		December 31, 2021			September 30, 2023		December 31, 2022
Deposit for fuel cell components (Note 15)		$	6,017	$	5,008
Deposit for fuel cell components (Note 16)						Deposit for fuel cell components (Note 16)	$	4,067	$	6,092
Vehicle inventory deposits	Vehicle inventory deposits	6,638		10,171		Vehicle inventory deposits	37		2,074
Production equipment deposits	Production equipment deposits	242		1,169		Production equipment deposits	482		235
Other prepaid expenses	Other prepaid expenses	4,673		3,266		Other prepaid expenses	1,338		1,877
Prepaid insurance	Prepaid insurance	4,345		5,079		Prepaid insurance	4,355		3,201
VAT receivable from government	VAT receivable from government	2,155		2,159		VAT receivable from government	1,231		1,886

Total prepaid expenses and other current assets	Total prepaid expenses and other current assets	$	24,070	$	26,852	Total prepaid expenses and other current assets	$	11,510	$	15,365

Table of Contents

Note 6.7. Property, Plant, and Equipment, net

Property, plant, and equipment, net consisted of the following (in thousands):


		September 30, 2022		December 31, 2021			September 30, 2023		December 31, 2022
Land and building	Land and building	$	2,818	$	2,818	Land and building	$	2,823	$	2,818
Machinery and equipment	Machinery and equipment	16,197		8,827		Machinery and equipment	13,873		15,832
Software	Software	2,071		507		Software	3,240		2,350
Leasehold improvements	Leasehold improvements	1,356		746		Leasehold improvements	2,904		2,123
Construction in progress	Construction in progress	5,081		2,139		Construction in progress	2,366		2,499
Total Property, plant, and equipment	Total Property, plant, and equipment	27,523		15,037		Total Property, plant, and equipment	25,206		25,622
Less: Accumulated depreciation and amortization	Less: Accumulated depreciation and amortization	(2,654)		(691)		Less: Accumulated depreciation and amortization	(5,657)		(3,202)
Property, plant and equipment, net	Property, plant and equipment, net	$	24,869	$	14,346	Property, plant and equipment, net	$	19,549	$	22,420

Depreciation and amortization expense totaled $1.0 million and $3.2 million for the three and nine months ended September 30, 2023, respectively. Depreciation and amortization expense totaled $0.8 million and $2.1 million for the three and nine months ended September 30, 2022, respectively. ~~Depreciation~~

The Company recognized impairment charges of $1.8 million during the three and ~~amortization expense totaled $0.2 million~~nine months ended September 30, 2023, related to restructuring in Hyzon Europe (see Note 4. Restructuring and ~~$0.5 million~~Related Charges). There were no property, plant and equipment impairment charges for the three and nine months ended September 30, ~~2021,~~2022.

Additionally, outside of the restructuring in Hyzon Europe, the Company recorded write-downs of other property and equipment of $1.8 million during the three months ended September 30, 2023, which consist of $1.1 million in Research and development expense, and $0.7 million in Selling, general, and administrative expense in the Consolidated Statements of Operations and Comprehensive Income (Loss), respectively. The Company recorded write-downs of other property and equipment of $2.1 million during the nine months ended September 30, 2023, which consist of $1.4 million in Research and development expense, and $0.7 million in Selling, general, and administrative expense, respectively.

Note 7.8. Accrued ~~liabilities~~Liabilities

Accrued liabilities consisted of the following (in thousands):


		September 30, 2022		December 31, 2021			September 30, 2023		December 31, 2022
Payroll and payroll related expenses	Payroll and payroll related expenses	$	3,904	$	2,250	Payroll and payroll related expenses	$	6,314	$	4,638
Accrued professional fees	Accrued professional fees	5,325		2,450		Accrued professional fees	3,432		10,016
Accrued product warranty costs	Accrued product warranty costs	903		816		Accrued product warranty costs	856		942
Accrued contract manufacturer costs	Accrued contract manufacturer costs	1,346		—		Accrued contract manufacturer costs	1,335		1,409
Accrued contract termination costs (Note 12)		2,430		—
Accrued Orten cancellation costs (Note 1)		1,617		—
Accrued severance		475		—
Accrued contract termination costs						Accrued contract termination costs	448		2,688
Accrued Orten cancellation costs						Accrued Orten cancellation costs	—		1,192
Accrued SEC settlement (Note 13)						Accrued SEC settlement (Note 13)	8,500		—
Other accrued expenses	Other accrued expenses	2,586		1,254		Other accrued expenses	2,008		4,702
Accrued liabilities	Accrued liabilities	$	18,586	$	6,770	Accrued liabilities	$	22,893	$	25,587

Table of Contents

Note 8.9. Investments in Equity Securities

The Company owns common shares, participation rights, and options to purchase additional common shares in certain private companies. On a non-recurring basis, the carrying value is adjusted for changes resulting from observable price changes in orderly transactions for identical or similar investments in the same issuer or an impairment.

There was no gain or loss on equity securities in the unaudited interim Consolidated Statements of Operations and Comprehensive Income (Loss) for the three and nine months ended September 30, 2023. Included in the Gain (loss) on equity securities in the unaudited interim Consolidated Statements of Operations and Comprehensive Income (Loss) for the nine months ended September 30, 2022 is a $12.5 million gain related to the equity investment in Raven SR, Inc. (“~~Raven”~~Raven SR”). The investment in ~~Raven’s~~Raven SR’s common shares and options ~~were~~was initially accounted for at cost of $2.5 million. In March 2022, there was an observable change in price of Raven’s common shares. The change in observable price of Raven’s common shares also results in a remeasurement of the investment in Raven’s options as of the date that the observable transaction took place. The fair value of the investment in Raven’s common shares was determined based on observable market prices of identical instruments in less active markets and is classified accordingly as Level 2 in the fair value hierarchy. Due to certain anti-dilution rights included in the options held by the Company, the fair value was determined utilizing a Monte-Carlo simulation model. Accordingly, this was determined to be a Level 3 measurement in the fair value hierarchy. The most significant assumptions in the model included the transaction price of the underlying common shares at the transaction date, expected volatility, risk free rate, and certain assumptions around the likelihood, size, and timing of potential future equity raises by Raven. As of March 31, 2022, the period end in which the observable change in price occurred, the Company determined the fair value of the investment in Raven’s common shares and options to be $6.5 million and $8.5 million, respectively.

Additionally, included in Gain (loss) on equity securities in the unaudited interim Consolidated Statements of Operations and Comprehensive Income (Loss) for the nine months ended September 30, 2022 is a $2.4 million impairment loss related to the Company’s investment in Global NRG H2 Limited (“NRG”), a New Zealand corporation, equal to the initial cost basis. In accordance with ASC 321, Investments - Equity ~~Securitie~~Securities~~s (“ASC 321”)~~, the investment in NRG does not have a readily determinable fair value and is measured at cost minus impairment, which requires the Company to evaluate on an ongoing basis whether an investment has been impaired based on qualitative factors. The Company impaired NRG due to the investee’s lack of progress in developing its plans and operating performance. ~~There was no gain (loss) on~~ ~~equity securities in the unaudited interim Consolidated Statements of Operations and Comprehensive Income (Loss) for the three months ended September 30, 2022.~~

The following table summarizes the total carrying value of held securities, measured as the total initial cost plus cumulative net gain (loss) (in thousands):


		September 30, 2022		December 31, 2021			September 30, 2023		December 31, 2022
Total initial cost basis	Total initial cost basis	$	4,948	$	4,948	Total initial cost basis	$	4,948	$	4,948
Adjustments:	Adjustments:					Adjustments:
Cumulative unrealized gain	Cumulative unrealized gain	12,530		—		Cumulative unrealized gain	12,530		12,530
Cumulative impairment	Cumulative impairment	(2,448)		—		Cumulative impairment	(2,448)		(2,448)
Carrying amount, end of period	Carrying amount, end of period	$	15,030	$	4,948	Carrying amount, end of period	$	15,030	$	15,030

The following table summarizes unrealized gain and impairment recorded in Other income (expense) in the unaudited interim Consolidated Statements of Operations and Comprehensive Income (Loss), which are included as adjustments to the carrying value of equity securities (in thousands):


		Three Months Ended September 30,				Nine Months Ended September 30,					Three Months Ended September 30,				Nine Months Ended September 30,
		2022		2021		2022		2021			2023		2022		2023		2022
Unrealized gain on equity securities	Unrealized gain on equity securities	$	—	$	—	$	12,530	$	—	Unrealized gain on equity securities	$	—	$	—	$	—	$	12,530
Cumulative impairment		—		—		(2,448)		—
Impairment										Impairment	—		—		—		(2,448)
Total unrealized gain and impairment on equity securities	Total unrealized gain and impairment on equity securities	$	—	$	—	$	10,082	$	—	Total unrealized gain and impairment on equity securities	$	—	$	—	$	—	$	10,082

Table of Contents

Note 9.10. Short-term Investments

The following ~~table summarizes~~tables summarize the Company's short-term investments as of September 30, 2023 and December 31, 2022 (in thousands):


		As of September 30, 2022									As of September 30, 2023
		Amortized Cost		Unrealized Gains		Unrealized Losses		Fair Value			Amortized Cost		Unrealized Gains		Unrealized Losses		Fair Value
Short-term investments	Short-term investments									Short-term investments
Certificates of deposit		$	105,097	$	175	$	(87)	$	105,186
Commercial paper		47,197		105		—		47,302

Corporate debt securities	Corporate debt securities	39,780		—		(181)		39,598		Corporate debt securities	$	2,230	$	—	$	—	$	2,230
Foreign government bonds		3,187		—		—		3,187

U.S. Treasury bills	U.S. Treasury bills	44,287		95		(7)		44,375		U.S. Treasury bills	24,363		600		—		24,963
Total short-term investments	Total short-term investments	$	239,548	$	375	$	(275)	$	239,648	Total short-term investments	$	26,593	$	600	$	—	$	27,193

~~The Company did not have any short-term investments as of December 31, 2021.~~


	As of December 31, 2022
	Amortized Cost		Unrealized Gains		Unrealized Losses		Fair Value
Short-term investments
Certificates of deposit	$	38,703	$	194	$	—	$	38,897
Commercial paper	26,198		205		—		26,403
Corporate debt securities	46,826		189		(33)		46,982
Foreign government bonds	37,453		348		—		37,801
U.S. Treasury bills	44,333		359		—		44,692
Total short-term investments	$	193,513	$	1,295	$	(33)	$	194,775

Note ~~10.~~11. Income Taxes

~~For~~During the three and nine months ended September 30, 2023 the Company did not record any tax expense. During the three and nine months ended September 30, 2022, the Company recorded a ~~net~~zero tax expense and a discrete tax expense of $0.5 million, respectively. The discrete item in the nine months ended September 30, 2022 was primarily associated with the establishment of a deferred tax liability that is not expected to offset available deferred tax assets. The Company did not record a provision for income taxes for the three months ended September 30, 2022, because the Company generated tax losses. The Company did not record a provision for income taxes for the three and nine months ended September 30, 2021 because the Company generated tax losses.

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The Company assesses all available evidence, both positive and negative, to determine the amount of any required valuation allowance within each taxing jurisdiction. The Company continues to be in a net operating loss and net deferred tax asset position, before valuation allowances. Full valuation allowances, but for the deferred tax liability described above, have been established for the Company’s operations in all jurisdictions. As of September 30, 2022, and December 31, 2021, the Company had net deferred tax assets of approximately $43.2 million and $23.0 million, respectively, each of which was fully offset by a valuation allowance.

There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, ~~2022~~2023 and December 31, ~~2021.~~2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its positions. The Company is subject to income tax examinations by taxing authorities in the countries in which it operates since inception.

Table of Contents

Note ~~11.~~12. Fair Value Measurements

The Company follows the guidance in ASC 820,Fair Value Measurement. For assets and liabilities measured at fair value on a recurring and nonrecurring basis, a three-level hierarchy of measurements based upon observable and unobservable inputs is used to arrive at fair value. The Company uses valuation approaches that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels:

•Level 1 inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date.

•Level 2 inputs: Other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability.

•Level 3 inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at measurement date.

As of September 30, ~~2022,~~2023, and December 31, ~~2021,~~2022, the carrying ~~amount~~amounts of accounts receivable, prepaid expenses and other current assets, accounts payable, and accrued liabilities approximate estimated fair value due to their relatively short maturities.

The following tables present information about the Company’s assets and liabilities that are measured at fair value on a recurring basis and ~~indicates~~indicate the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value (in thousands):


		As of September 30, 2022									As of September 30, 2023
		Level 1		Level 2		Level 3		Total			Level 1		Level 2		Level 3		Total
Assets:	Assets:									Assets:
Cash equivalents:	Cash equivalents:	$	16,330	$	24,283	$	—	$	40,613	Cash equivalents:	$	82,204	$	—	$	—	$	82,204
Short-term investments:	Short-term investments:									Short-term investments:
Certificates of deposit		—		105,186		—		105,186
Commercial paper		—		47,302		—		47,302

Corporate debt securities	Corporate debt securities	—		39,598		—		39,598		Corporate debt securities	—		2,230		—		2,230
Foreign government bonds		—		3,187		—		3,187
U.S. Treasury bill		44,375		—		—		44,375

U.S. Treasury bills										U.S. Treasury bills	24,963		—		—		24,963
Liabilities:	Liabilities:									Liabilities:
Warrant liability – Private Placement Warrants	Warrant liability – Private Placement Warrants	$	—	$	1,843	$	—	$	1,843	Warrant liability – Private Placement Warrants	$	—	$	561	$	—	$	561
Earnout shares liability	Earnout shares liability	—		—		16,390		16,390		Earnout shares liability	—		—		4,898		4,898


		As of December 31, 2021									As of December 31, 2022
		Level 1		Level 2		Level 3		Total			Level 1		Level 2		Level 3		Total
Assets:										Assets:
Cash equivalents:										Cash equivalents:	$	23,113	$	4,992	$	—	$	28,105
Short-term investments:										Short-term investments:
Certificates of deposit										Certificates of deposit	—		38,897		—		38,897
Commercial paper										Commercial paper	—		26,403		—		26,403
Corporate debt securities										Corporate debt securities	—		46,982		—		46,982
Foreign government bonds										Foreign government bonds	—		37,801		—		37,801
U.S. Treasury bills										U.S. Treasury bills	44,692		—		—		44,692
Liabilities:	Liabilities:									Liabilities:
Warrant liability – Private Placement Warrants	Warrant liability – Private Placement Warrants	$	—	$	15,228	$	—	$	15,228	Warrant liability – Private Placement Warrants	$	—	$	1,122	$	—	$	1,122
Earnout shares liability	Earnout shares liability	—		—		103,761		103,761		Earnout shares liability	—		—		10,927		10,927

Cash Equivalents

The Company’s cash equivalents consist of short-term, highly liquid financial instruments that are readily convertible to cash with original maturities of three months or less. As of September 30, 2023, the Company has $82.2 million invested in money market funds and certificates of deposit. As of December 31, 2022, the Company ~~has $40.6~~had $28.1 million invested in commercial paper ~~certificates of deposit~~ and money market funds. The Company classifies its investments in commercial paper ~~and certificates of deposit~~ as Level 2 because they are valued using inputs other than quoted prices which are directly or indirectly observable in the market, including readily available pricing sources for the identical underlying security which may not be actively traded.

Short-term Investments

The Company’s short-term investments consist of ~~high-quality, investment-grade~~high quality, investment grade marketable debt securities and are classified as available-for-sale. The Company classifies its investments in certificates of deposit, commercial paper, corporate debt securities and foreign government bonds as Level 2 because they are valued using inputs other than quoted prices which are directly or indirectly observable in the market, including readily available pricing sources for the identical underlying security which may not be actively traded.

Earnout to Common Stockholders

The fair value of the earnout shares was estimated by utilizing a Monte-Carlo simulation model. The inputs into the Monte-Carlo pricing model included significant unobservable inputs. The following table provides quantitative information regarding Level 3 fair value measurement inputs:


		September 30, 2022			December 31, 2021				September 30, 2023			December 31, 2022
Stock price	Stock price	$	1.70		$	6.49		Stock price	$	1.25		$	1.55
Risk-free interest rate	Risk-free interest rate	4.2		%	1.2		%	Risk-free interest rate	4.9		%	4.2		%
Volatility	Volatility	98.0		%	90.0		%	Volatility	92.0		%	92.0		%
Remaining term (in years)	Remaining term (in years)	3.79			4.54			Remaining term (in years)	2.79			3.54

The following table presents the changes in the liabilities for Private Placement Warrants and Earnout for the nine months ended September 30, ~~2022~~2023 (in thousands):

Private Placement Warrants Earnout
Balance as of December 31, 2021 $ 15,228 $ 103,761
Change in estimated fair value (13,385) (87,371)
Balance as of September 30, 2022 $ 1,843 $ 16,390


	Private Placement Warrants		Earnout
Balance as of December 31, 2022	$	1,122	$	10,927
Change in estimated fair value	(561)		(6,029)
Balance as of September 30, 2023	$	561	$	4,898

The Company performs routine procedures such as comparing prices obtained from independent sources to ensure that appropriate fair values are recorded.

Assets Measured on a Nonrecurring Basis

Assets that are measured at fair value on a nonrecurring basis are remeasured when carrying value exceeds fair value. This includes the evaluation of long-lived assets. Where an indication of an impairment exists, the Company’s estimates of fair value of long-lived assets require the use of significant unobservable inputs, representative of Level 3 fair value measurements, including numerous assumptions with respect to future circumstances that might directly impact the long-lived assets’ operations in the future and are therefore uncertain.

The Company assesses the carrying amount of long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company uses undiscounted future cash flows of the asset or asset group for equipment and intangible assets. The Company assessed the fair value of the relevant long-lived assets using the income approach. Inputs used to calculate the fair value based on the income approach primarily include estimated future cash flows, discounted at a rate that approximates the cost of capital of a market participant.

During the quarter ended September 30, 2023, the Company recognized an impairment charge of $4.6 million ($2.8 million of right-of-use asset and $1.8 million of property, plant and equipment, net) as a result of restructuring at Hyzon Europe (See Note 4. Restructuring and Related Charges).

~~Table of Contents~~

Note ~~12.~~13. Commitments and Contingencies

Legal Proceedings

The Company is subject to, and may become a party to, a variety of litigation, other claims, suits, indemnity demands, regulatory actions, and government investigations and inquiries in the ordinary course of business. The assessment as to whether a loss is probable or reasonably possible, and as to whether such loss or a range of such loss is estimable, often involves significant judgment about future events, and the outcome of litigation is inherently uncertain. The Company accrues for matters when we believe that losses are probable and can be reasonably estimated. ~~As of September 30, 2022, the Company accrued $2.4 million in Accrued liabilities in the unaudited interim Consolidated Balance Sheets. The Company did not record any accruals as of December 31, 2021.~~

As the outcome of individual matters is not predictable with assurance, the assessments are based on the Company’s knowledge and information available at the time; thus, the ultimate outcome of any matter could require payment substantially in excess of the amount being accrued and/or disclosed. The Company is party to current legal proceedings as discussed more fully below.

Shareholder Securities and Derivative Litigation

Three related putative securities class action lawsuits were filed between September 30, 2021 and November 15, 2021, in the U.S. District Court for the Western District of New York against the Company, certain of the Company’s current and former officers and directors and certain former officers and directors of ~~DCRB~~Decarbonization Plus Acquisition Corporation (“DCRB”) and DCRB’s sponsor (Kauffmann v. Hyzon Motors Inc., et al. (No. 21- cv-06612-CJS), Brennan v. Hyzon Motors Inc., et al. (No. 21-cv-06636-CJS), and Miller v. Hyzon Motors Inc. et al. (No. 21-cv-06695-CJS)), asserting violations of federal securities laws. The complaints generally allege that the Company and individual defendants made materially false and misleading statements relating to the nature of the Company’s customer contracts, vehicle orders, and sales and earnings projections, based on allegations in a report released on September 28, 2021, by Blue Orca Capital, an investment firm that indicated that it held a short position in the Company’s stock and which has made numerous allegations about the Company. These lawsuits have been consolidated under the caption In re Hyzon Motors Inc. Securities Litigation (Case No. 6:21-cv-06612-CJS-MWP), and on March 21, 2022, the court-appointed lead plaintiff filed a consolidated amended complaint seeking monetary damages. The Company and individual defendants moved to dismiss the consolidated amended complaint on May 20, 2022, and the court-appointed lead plaintiff filed its opposition to the motion on July 19, 2022. The court-appointed lead plaintiff filed an amended complaint on March 21, 2022, and a second amended complaint on September 16, 2022. Briefing regarding the Company and individual defendants’ anticipated motion to dismiss the second amended complaint ~~has been~~was stayed pending a ~~scheduled,~~ non-binding mediation among the ~~parties. There is no assurance that the mediation will proceed as scheduled, or that, if mediation occurs, any or all~~ parties, ~~will~~which took place on May 9, 2023. The parties did not reach a ~~settlement.~~settlement during the May 9, 2023 mediation. On June 20, 2023, the court granted the lead plaintiff leave to file a third amended complaint, which was filed on June 23, 2023.The third amended complaint added additional claims. The Company filed a motion to dismiss on September 13, 2023, and DCRB and former DCRB officers, directors, and its sponsor filed a motion to dismiss on the same day. The lead plaintiff filed oppositions to the motions to dismiss on October 25, 2023, and defendants’ replies are due November 22, 2023.

Between December 16, 2021, and January 14, 2022, three related shareholder derivative lawsuits were filed in the U.S. District Court for the Western District of New York (Lee v. Anderson et al. (No. 21-cv-06744-CJS), Révész v. Anderson et al. (No. 22-cv-06012-CJS), and Shorab v. Anderson et al. (No. 22-cv-06023-CJS)). These three lawsuits have been consolidated under the caption In re Hyzon Motors Inc. Derivative Litigation (Case No. 6:21-cv-06744-CJS). On February 2, 2022, a similar ~~shareholder~~stockholder derivative lawsuit was filed in the U.S. District Court for the District of Delaware (Yellets v. Gu et al. (No. 22-cv-00156)). On February 3, 2022, a similar shareholder derivative lawsuit was filed in the Supreme Court of the State of New York, Kings County (Ruddiman v. Anderson et al. (No. 503402/2022)). On February 13, 2023, a similar ~~shareholder~~stockholder derivative lawsuit was filed in the Delaware Court of Chancery (Kelley v. Knight et al. (C.A. No. 2023-0173)). These lawsuits name as defendants certain of the Company’s current and former directors and certain former directors of DCRB, along with the Company as a nominal defendant, and generally allege that the individual defendants breached their fiduciary duties by making or failing to prevent the misrepresentations alleged in the consolidated securities class action, and assert claims for violations of federal securities laws, breach of fiduciary duties, unjust enrichment, abuse of control, gross mismanagement, and/or waste of corporate assets. These lawsuits generally seek equitable relief and monetary damages. ~~With the exception of the recently filed action in the Delaware Court of Chancery, each~~Each of the shareholder derivative actions has been stayed or the parties have jointly requested that itthe actions be stayed pending a decision regarding the anticipated motion to dismiss in the consolidated securities class action.

~~Table of Contents~~

On March 18, 2022, a putative class action complaint, Malork v. Anderson et al. (C.A. No. 2022-0260- KSJM), was filed in the Delaware Court of Chancery against certain officers and directors of DCRB, DCRB’s sponsor, and certain investors in DCRB’s sponsor, alleging that the director defendants and controlling ~~shareholders~~stockholders of DCRB’s sponsor breached their fiduciary duties in connection with the merger between DCRB and Legacy Hyzon. The complaint seeks equitable relief and monetary damages. On May 26, 2022, the defendants in this case moved to dismiss the complaint. On August 2, 2022, the plaintiff filed an amended complaint. Defendants filed a motion to dismiss the amended complaint on August 15, 2022. Briefing on the motion to dismiss is now complete, and oral argument occurred on April 21, 2023. On July 17, 2023, the Delaware Court of Chancery denied the defendants’ motion to dismiss the complaint.

Between January 26, 2022 and August 22, 2022, Hyzon received demands for books and records pursuant to Section 220 of the Delaware General Corporation Law from four stockholders who state they are investigating whether to file similar derivative or stockholder lawsuits, among other purposes. On May 31, 2022, one of these four stockholders represented that he had concluded his investigation and did not intend to file a complaint. On November 18, 2022, a second of the four stockholders filed a lawsuit in the Delaware Court of Chancery (Abu Ghazaleh v. Decarbonization Plus Acquisition Sponsor, LLC et al. (C.A. No. 2022-1050)), which was voluntarily dismissed shortly thereafter on December 1, 2022. On February 13, 2023, a third of these four ~~shareholders~~stockholders filed a derivative lawsuit in the Delaware Court of Chancery (Kelley v. Knight et al. (C.A. No. 2023-0173)). The complaint asserts claims for breach of fiduciary duty and generally alleges that the individual defendants breached their fiduciary duties by making or failing to prevent misrepresentations including those alleged in the consolidated securities class action and the report released by Blue Orca Capital. As with the previously filed ~~shareholder~~stockholders derivative lawsuits, the complaint seeks equitable relief and monetary damages. On April 17, 2023, the Court entered an order staying this action pending a decision on the anticipated motion to dismiss in the consolidated securities class action.

On April 18, 2023, the Company received a demand for books and records pursuant to Section 220 of the Delaware General Corporation Law from a stockholder seeking to investigate possible breaches of fiduciary duty or other misconduct or wrongdoing by the Company's controlling stockholder, Hymas Pte. Ltd. ("Hymas"), Hyzon's ~~board~~Board of ~~directors~~Directors (the "Board") and/or certain members of Hyzon's senior management team in connection with the Company's entrance into (i) an equity transfer agreement (the "Equity Transfer") with certain entities affiliated with the Company, and (ii) the share buyback agreement with the Hymas (the "Share Buyback" and, together with the Equity Transfer, the "Transactions") as reported by the Company in its Form 8-K filed on December 28, 2022.

The above proceedings are subject to uncertainties inherent in the litigation process. The Company cannot predict the outcome of these matters or estimate the possible loss or range of possible loss, if any at this time.

Government Investigations

On January 12, 2022, the Company announced it received a subpoena from the SEC for production of documents and information, including documents and information related to the allegations made in the September 28, 2021 report issued by Blue Orca Capital. The Company received two additional subpoenas in connection with the SEC’s investigation on August 5, 2022 and August 10, 2022. On October 31, 2022, the U.S. Attorney’s Office for the Southern District of New York (“SDNY”) notified the Company that it iswas also investigating these matters. The Company is cooperating and will continue to cooperate with these and any other regulatory or governmental investigations or inquiries. The Company cannot predict the ultimate outcome of the SEC and the SDNY investigations or inquiries. It is not possible to accurately predict at this time when matters will be completed, the final outcome as a result of those investigations or inquiries, what if any actions may be taken by the SEC or the SDNY, or the effect that such actions may have on our business, prospects, operating results and financial condition, which could be material.

17On September 26, 2023, the Company announced a final resolution, subject to court approval, of the SEC’s investigation. On that date, the SEC filed a complaint in the U.S. District Court for the Western District of New York naming the Company, Craig Knight, the Company’s former Chief Executive Officer and a former director, and Max C.B. Holthausen, a former managing director of the Company’s European subsidiary, Hyzon Motors Europe B.V., as defendants. Without admitting or denying the allegations in the SEC’s complaint, the Company consented to the entry of a final judgment, subject to court approval, that would permanently restrain and enjoin the Company from violating certain sections of and rules under the Exchange Act and the Securities Act, and would require the Company to pay a civil penalty of $25.0 million as follows: $8.5 million within 30 days of entry of the final judgment; (2) $8.5 million by December 31, 2024; and (3) $8.0 million within 730 days of entry of the final judgment. Mr. Knight and Mr. Holthausen also separately consented to the entry of final judgments, subject to court approval, resolving the SEC’s allegations.

~~Table~~

Delaware Court of ~~Contents~~Chancery Section 205

On February 13, 2023, the Company filed a petition under the caption In re Hyzon Motors Inc., C.A. No. 2023-0177-LWW (Del. Ch) in the Delaware Court of Chancery pursuant to Section 205 of the Delaware General Corporation Law (“DGCL”), which permits the Court of Chancery, in its discretion, to validate potentially defective corporate acts due to developments regarding potential interpretations of the DGCL stemming from the Court’s recent decision in Garfield v. Boxed, Inc., 2022 WL 17959766 (Del. Ch. Dec. 27, 2022). On March 6, 2023, the Court of Chancery granted our petition, holding that any defects that may have existed with respect to the conduct of the Special Meeting of Shareholders held on July 15, 2021, to approve the increase in the Company’s authorized share capital were ratified as of the meeting.

The Company continues to believe that, notwithstanding the relief the Delaware Court of Chancery granted to the Company under Section 205, at the time of DCRB Shareholder Meeting on July 16, 2021, the increase in the Company’s authorized share capital was validly approved by DCRB’s shareholders under Delaware law.

Customer and Supplier ~~Dispute~~Disputes

From time to time, the Company is subject to various commercial disputes or claims with its customers or suppliers. In January 2023, Duurzaam Transport B.V. and H2 Transport B.V., both private limited companies in the Netherlands and customers of the Company’s European subsidiary, Hyzon ~~Motors~~ Europe, ~~B.V. (“Hyzon Europe”),~~ filed an attachment with the local Dutch court. The initial attachment claimed that Hyzon Europe was liable for liquidated and consequential damages stemming from Hyzon Europe allegedly not delivering trucks as contracted. The initial attachment placed a lien on the assets of Hyzon Europe. Following the attachments, Duurzaam Transport B.V. and H2 Transport B.V. initiated proceedings on the merits in February 2023. ~~Eventually, the~~The dispute was settled without any party admitting liability, and the Company made a payment of €2.1 million (approximately ~~$2.0~~$2.3 million in USD) in April 2023, which was recorded in Accrued liabilities in the ~~unaudited interim~~ Consolidated Balance Sheets as of ~~September 30,~~December 31, 2022.

On July 28, 2023, Worthington Industries Poland SP.Z.O.O, a Hyzon Europe supplier, filed a complaint in the Amsterdam District Court in the Netherlands, against Hyzon Europe for breach of contract and obtained an attachment covering Hyzon Europe’s bank accounts. The complaint seeks damages from Hyzon Europe totaling €4.6 million (approximately $4.9 million in USD). The Company intends to vigorously defend itself against this claim.

Regardless of outcome, such proceedings or claims can have an adverse impact on the Company because of legal defense and settlement costs, the Company’s obligations to indemnify third parties, diversion of resources, and other factors, and there can be no assurances that favorable outcomes will be obtained. Based on the early-stage nature of these cases, the Company cannot predict the outcome of these currently outstanding customer and supplier dispute matters or estimate the possible loss or range of possible loss, if any.

~~Table of Contents~~

Note ~~13.~~14. Stock-based Compensation Plans

The following table summarizes the Company’s stock option, ~~and~~ Restricted Stock ~~Unit~~Units (“~~RSU”~~RSUs”) and Performance Stock Units (“PSUs”) activity:

Stock Options RSUs
Number of Options Weighted Average Exercise Price Weighted Average Remaining Contractual (Years) Aggregate Intrinsic Value (in 000s) Number of RSUs Weighted Average Grant Date Fair Value
Outstanding at December 31, 2021 19,311,140 $ 1.29 13.07 100,885 1,852,685 $ 6.14
Granted 539,292 $ 4.64 — — 1,260,408 $ 3.72
Exercised or released (38,868) $ 1.13 — — (468,778) $ 6.79
Forfeited/Cancelled (83,284) $ 1.13 — — (106,128) $ 5.15
Outstanding at September 30, 2022 19,728,280 $ 1.51 12.17 8,054 2,538,187 $ 4.86
Vested and expected to vest, September 30, 2022 14,190,780 $ 1.21 11.74 8,054 2,538,187 $ 4.86
Exercisable and vested at September 30, 2022 12,410,743 $ 1.13 12.54 7,091 —


	Stock Options					RSUs			PSUs
	Number of Options	Weighted Average Exercise Price		Weighted Average Remaining Contractual (Years)	Aggregate Intrinsic Value (in 000s)	Number of RSUs	Weighted Average Grant Date Fair Value		Number of PSUs	Weighted Average Grant Date Fair Value
Outstanding at December 31, 2022	19,536,904	$	1.51	12.00	5,972	6,268,193	$	2.81	—	$	—
Granted	1,261,130	$	1.37	—	—	7,567,847	$	0.97	2,969,375	$	0.98
Exercised or released	(16,000)	$	1.13	—	—	(630,420)	$	3.08	—	$	—
Forfeited/Cancelled	(5,934,298)	$	2.26	—	—	(1,274,518)	$	2.98	—	$	—
Outstanding at September 30, 2023	14,847,736	$	1.22	10.58	—	11,931,102	$	1.61	2,969,375	$	0.98
Vested and expected to vest, September 30, 2023	14,847,736	$	1.22	10.58	—	11,931,102	$	1.61	2,969,375	$	0.98
Exercisable and vested at September 30, 2023	12,839,987	$	1.19	11.39	—	—	—		—	—

As of September 30, ~~2022,~~2023, there was ~~$2.7~~$1.0 million of unrecognized stock-based compensation expense related to unvested stock options, which is expected to be recognized over a weighted-average period of ~~3.5~~1.84 years.

RSUs granted under the Company’s equity incentive plans typically vest over a ~~four~~one ~~or five-year~~to four-year period beginning on the date of grant. RSUs will be settled through the issuance of an equivalent number of shares of the Company’s common stock and are equity classified.

In 2023, the Company granted PSUs to certain members of management, which vest over a three-year period beginning on the date of grant. Subject to the achievement of performance goals during a performance period outlined by the Compensation Committee of the Board of Directors, upon vesting, the PSUs are exchanged for a number of shares of common stock equal to the target number of PSUs multiplied by a factor between 0% and 150%. The actual number of units that ultimately vest may equal, exceed, or be less than the targeted number of shares based on the level of achievement of performance goals over the performance period and continued employment with the Company. Performance goals are based on a combination of internal company, functional and individual employee performance metrics. The Company adjusts the expense recognized based on the likelihood of future achievement of the performance metric. If the performance metrics are not achieved by the outlined performance period, the awards are forfeited.

The total fair value of ~~restricted shares~~RSUs and PSUs is determined based upon the stock price on the date of grant. As of September 30, ~~2022,~~2023, unrecognized compensation costs related to unvested RSUs of ~~$11.1~~$15.0 million is expected to be recognized over a remaining weighted average period of ~~3.09~~2.48 years. As of September 30, 2023, unrecognized compensation costs related to unvested PSUs of $2.6 million is expected to be recognized over a remaining weighted average period of 2.63 years.

Earnout to Other Equity Holders

~~Earnout~~Certain earnout awards to other equity holders accounted for under ASC 718, Compensation - Stock Compensation~~(“ASC 718”)~~ were vested at the time of grant, and therefore recognized immediately as compensation ~~expense.~~expense, and certain earnout awards vest over future periods. Total compensation ~~expense/(benefit) recorded~~expense related to these awards was negligible and $0.1 million for the three and nine months ended September 30, ~~2022~~2023, respectively. Total compensation expense/(benefit) related to these ~~earnout~~ awards was $(0.1) million and $0.8 million ~~respectively. Total compensation expense recorded~~ for the three and nine months ended and September 30, ~~2021 related to these earnout awards was $14.0 million.~~2022, respectively. Certain earnout awards to other equity holders contained performance and market-based vesting conditions, and as the performance conditions are not deemed probable at September 30, ~~2022,~~2023, no compensation expense has been recorded related to these awards.

1917

~~Table of Contents~~

Note ~~14.~~15. Stockholders' Equity

Common Stock

The Company is authorized to issue 400,000,000 shares of common stock with a par value of $0.0001 per share. Holders of Class A common stock are entitled to one vote for each share. At September 30, ~~2022~~2023 and December 31, ~~2021,~~2022, there were ~~248,153,362~~244,998,491 and ~~247,758,412~~244,509,208 shares of Class A common stock issued and outstanding, respectively.

Warrants

At September 30, 2023 and December 31, 2022, there were 11,013,665 Public Warrants and 8,014,500 Private Placement Warrants, for a total of 19,028,165 warrants outstanding. At ~~December 31, 2021, there were 11,286,242 Public Warrants and 8,014,500 Private Placement Warrants, for a total of 19,300,742 warrants outstanding. At~~ September 30, ~~2022,~~2023 and December 31, ~~2021,~~2022, there were 170,048 ~~and 275,048~~ Ardour Warrants ~~outstanding, respectively.~~outstanding.

~~Equity Repurchase Program~~

On November 17, 2021, the Company’s board of directors authorized the repurchase of up to $5.0 million of its outstanding common stock and/or Public Warrants. The timing and amount of any share repurchases under the Company’s share repurchase authorization will be determined by management based on market conditions and other considerations. Such repurchases may be executed in the open market. As of December 31, 2021, the Company had repurchased 256,977 public warrants for $0.5 million. In the nine months ended September 30, 2022, the Company repurchased an additional 15,600 public warrants for $31 thousand. The Company repurchased a total of 272,577 public warrants and suspended the share repurchase program as of January 5, 2022.

~~Table of Contents~~

Note ~~15.~~16. Related Party Transactions

Horizon IP Agreement

In January 2021, the Company entered into an intellectual property agreement (the “Horizon IP Agreement”) with Jiangsu Qingneng New Energy Technologies Co., Ltd. and Shanghai Qingneng Horizon New Energy Ltd. (together, “JS Horizon”) both of which are subsidiaries of the Company’s ultimate parent, Horizon. In September 2021, Jiangsu Horizon Powertrain Technologies Co. Ltd. (“JS Powertrain”) was an added party to the agreement. Pursuant to the agreement the parties convey to each other certain rights in intellectual property relating to Hyzon’s core fuel cell and mobility product technologies, under which Hyzon was to pay JS Horizon and JS Powertrain a total fixed payment of $10.0 million. The full $10.0 million has been paid, $6.9 million was paid in 2021 and the remaining $3.1 million was paid in February 2022.

Hyzon Motors USA Inc., a subsidiary of the Company, entered into a Second Amendment (the “Second Amendment”) to the Horizon IP Agreement. The Second Amendment is effective September 22, 2023. Under the terms of the Second Amendment, the parties have agreed to certain amendments to the Horizon IP Agreement pertaining to their rights in and to hydrogen fuel cell intellectual property. The parties have also agreed to a term for the Horizon IP Agreement that shall expire on the seven-year anniversary of the effective date of the Second Amendment.

Related Party Payables and Receivables

Horizon Fuel Cell Technologies and Related Subsidiaries

~~The~~In prior periods, the Company made deposit payments to Horizon and its subsidiaries to secure ~~certain~~ fuel cell components. As of September 30, ~~2022,~~2023, the ~~remaining~~deposit balance ~~is $6.0~~was $4.1 million and included within Prepaid expenses and other current assets in the unaudited interim Consolidated Balance ~~Sheets.~~Sheet. The Company has cancelled certain orders that were previously made against this deposit balance, and the parties are currently in negotiations as to the resolution of this order cancellation matter and the settlement of the deposit balance. The Company has determined that the recovery of this deposit balance represents a contingency. The Company can not estimate the possible loss or range of possible loss, if any, at this time based on the current status of the negotiations.

Certain employees of Horizon and its subsidiaries provide research and development, staff training, and administrative services to the Company. Based on an analysis of the compensation costs incurred by Horizon and an estimate of the proportion of effort spent by such employees on each entity, an allocation of ~~approximately~~ ~~$0.4~~ $0.4 million and ~~$1.2~~$0.9 million in ~~was recorded in~~ the Company’s unaudited interim Consolidated Statements of Operations and Comprehensive Income (Loss) related to such services for the three and nine months ended September 30, 2022, a~~nd 2021,~~ respectively. ~~An allocation of approximately $0.9 million and~~ ~~$1.8 million~~ ~~was recorded in the Company’s unaudited interim Consolidated Statements of Operations and Comprehensive Income (Loss) related to~~There were no such ~~services~~activities for ~~the nine months ended September 30, 2022, and 2021, respectively.~~

~~The related party payable to Horizon and its subsidiaries is $0.1 million and $3.7 million as of September 30, 2022 and December 31, 2021, respectively.~~

~~Holthausen and Affiliates~~

The Company entered into a joint venture agreement in October 2020 to create Hyzon Europe with Holthausen Clean Technology Investments B.V. (“Holthausen”). As Hyzon Europe builds out its production facilities, it relies on Holthausen and its affiliates for certain production resources that result in related party transactions. In addition, both companies rely on certain suppliers, including Horizon.

The Company currently owns 50.5% of the equity interests of Hyzon Europe. On December 31, 2021, Hyzon executed a non-binding Letter of Intent (“LOI”) with Holthausen to increase its stake to 75% in Hyzon Europe. Concurrent with the signing of this LOI, a €1 million refundable deposit was paid to Holthausen, approximately $1.1 million in U.S. dollars (“USD”). This deposit is recorded within Prepaid expenses and other current assets in the unaudited interim Consolidated Balance Sheets.

Subsequently, in December 2022, the Company acquired the remaining 49.5% of the equity interests of Hyzon Europe from Holthausen. The Company now holds 100% ownership in Hyzon Europe. The Company paid €3.5 million (approximately $3.7 million in USD) in addition to €1.0 million (approximately $1.1 million in USD) paid in December 2021. As part of this transaction, the Company also transferred various inventory items to, and settled open related party balances with, Holthausen. In addition, the Company reassigned all of the assumed retrofit service contracts, including after-sales obligations, back to Holthausen Clean Technology B.V.

~~For~~ the three and nine months ended September 30, 2022, the Company paid $0.1 million and $0.4 million, respectively, to Carl Holthausen and Max Holthausen as managing directors of Hyzon Europe. For the three and nine months ended September 30, 2021, the Company paid $0.1 million and $0.3 million, respectively.2023.

As of September 30, ~~2022,~~2023, the related party payable, net to ~~Holthausen~~Horizon and its subsidiaries is ~~$0.3~~$0.1 million. AsThe related party receivable, net from Horizon and its subsidiaries was $6.1 million as of December 31, ~~2021,~~2022. The related party receivable, net at December 31, 2022 primarily relates to the divestiture of Hyzon Motors Technology (Guangdong) Co., Ltd. (“Hyzon Guangdong”), which was subsequently renamed to Guangdong Qingyun Technology Co. Ltd. (“Guangdong Qingyun”). In April 2023, the Company received $6.4 million to settle the related party receivable ~~from Holthausen is $0.3 million.~~

~~Jiushuang Joint Ventures~~

~~As described in Note 3. Revenue,~~associated with the ~~Company delivered 20 FCEVs to Jiushuang (Shanghai) New Energy Technology Co., Ltd. during the three months ended September 30, 2022. Jiushuang (Shanghai) New Energy Technology Co., Ltd. is a parent~~divestiture of ~~both Jiushuang Tiancheng Motors Service Ltd. (“JSTC”) and Jiushuang Suda Logistics Ltd. (“JSSD”), which the Company partnered with to form the Jiushuang joint ventures.~~Hyzon Guangdong.

2118

~~Table of Contents~~

Note ~~16.~~17. Income (Loss) per share

Basic net income (loss) per share is computed by dividing net income attributable to shareholders of Hyzon by the weighted-average number of common shares outstanding during the reporting period. Diluted net income per share is computed similarly to basic net income per share, except that it includes the potential dilution that could occur if dilutive securities were exercised.

The following table presents the information used in the calculation of the Company’s basic and diluted net income (loss) per share attributable to Hyzon common stockholders (in thousands, except per share data):

Three Months Ended
September 30, Nine Months Ended
September 30,
2022 2021 2022 2021
Net income (loss) attributable to Hyzon $ (24,795) $ 34,621 $ 10,681 $ 17,053
Weighted average shares outstanding:
Basic 248,164 234,091 248,054 189,101
Effect of dilutive securities — 12,389 9,774 11,883
Diluted 248,164 246,480 257,828 200,984
Net income (loss) per share attributable to Hyzon:
Basic $ (0.10) $ 0.15 $ 0.04 $ 0.09
Diluted $ (0.10) $ 0.14 $ 0.04 $ 0.08

~~The weighted average number of shares outstanding prior to Business Combination were converted at the Exchange Ratio.~~


	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Net income (loss) attributable to Hyzon	$	(44,054)	$	(24,795)	$	(134,550)	$	10,681
Weighted average shares outstanding:
Basic	244,885		248,164		244,686		248,054
Effect of dilutive securities	—		—		—		9,774
Diluted	244,885		248,164		244,686		257,828
Net income (loss) per share attributable to Hyzon:
Basic	$	(0.18)	$	(0.10)	$	(0.55)	$	0.04
Diluted	$	(0.18)	$	(0.10)	$	(0.55)	$	0.04

Potentially dilutive shares are excluded from the computation of diluted net income (loss) per share when their effect ~~was~~is antidilutive. The potential dilutive securities are summarized as follows (in thousands):


		Three Months Ended September 30,		Nine Months Ended September 30,			Three Months Ended September 30,		Nine Months Ended September 30,
		2022	2021	2022	2021		2023	2022	2023	2022
Restricted stock units	Restricted stock units	2,538	426	937	426	Restricted stock units	11,931	2,538	11,931	937
Performance stock units						Performance stock units	2,969	—	2,969	—
Stock options with service conditions	Stock options with service conditions	12,419	—	539	—	Stock options with service conditions	13,076	12,419	13,076	539
Stock options for former CTO	Stock options for former CTO	1,772	—	—	—	Stock options for former CTO	1,772	1,772	1,772	—
Stock options with market and performance conditions	Stock options with market and performance conditions	5,538	5,538	5,538	5,538	Stock options with market and performance conditions	—	5,538	—	5,538
Private placement warrants	Private placement warrants	8,015	8,015	8,015	8,015	Private placement warrants	8,015	8,015	8,015	8,015
Public warrants	Public warrants	11,014	11,286	11,014	11,286	Public warrants	11,014	11,014	11,014	11,014
Earnout shares	Earnout shares	23,250	23,250	23,250	23,250	Earnout shares	23,250	23,250	23,250	23,250
Hongyun warrants	Hongyun warrants	31	—	31	—	Hongyun warrants	31	31	31	31
Ardour warrants	Ardour warrants	170	326	—	326	Ardour warrants	170	170	170	—

2219

~~Table of Contents~~

~~Note 17. Subsequent Events~~

~~Raven SR S1 LLC~~

In December 2022, the Company entered into an agreement with Chevron New Energies and Raven, to invest in Raven SR S1 LLC. Raven SR S1 LLC intends to develop, construct, operate and maintain a solid waste-to hydrogen generation production facility located in Richmond, California. The Company invested $8.5 million at closing, and the remaining $1.5 million will be paid in 2023 for an approximate 20% ownership in Raven SR S1 LLC. The Company accounted for the agreement as an equity method investment with a cost basis determined by the funding date capital contribution. The subsequent payment will add to the overall cost basis of the investment when paid.

~~Divestiture of Hyzon Guangdong~~

In December 2022, the Company sold all of its equity interest in Hyzon Motors Technology (Guangdong) Co., Ltd. (“Hyzon Guangdong”) to Hymas for approximately $3.1 million in cash, subject to certain adjustments. As a common control transaction, the difference of $0.5 million between the consideration received and the book value is expected to be recognized in the Company’s additional paid-in-capital during the three months ended December 31, 2022. Subsequent to the divestiture, Hyzon Guangdong changed its name to Guangdong Qingyun Technology Co. Ltd. (“Guangdong Qingyun”).

Additionally, together with the execution of the Hyzon Guangdong divestiture, the Company entered into a share buyback agreement and repurchased approximately 3.8 million shares of common stock from Hymas in exchange for approximately $6.4 million in cash.

~~In April 2023, Guangdong Qingyun paid $3.3 million to the Company to settle intercompany balances and Hymas paid the Company $3.1 million related to the Hyzon Guangdong divestiture.~~

~~Nasdaq Deficiency Notice~~

In February 2023, the Company received a Staff Determination from the Listing Qualifications Staff of Nasdaq notifying the Company that unless the Company requests an appeal, trading of the Company's Class A common stock and warrants will be suspended from The Nasdaq Capital Market at the opening of business on February 14, 2023, and a Form 25-NSE will be filed with the SEC. On February 10, 2023, the Hearings Panel granted the Company a 15 calendar day stay of delisting, and will notify the Company within this 15 calendar day period whether the Company’s request for a stay pending the hearing will be granted. The date for the delisting hearing was March 16, 2023. At the hearing, the Company presented its plan to regain compliance with Nasdaq Listing Rule 5250(c)(1) and requested the continued listing of its securities on The Nasdaq Capital Market pending such compliance. In March 2023, the Company received a letter from the Hearings Panel indicating that the Hearings Panel granted the Company’s request for continued listing until May 15, 2023, in order to allow the Company to regain compliance with the periodic filing rule.

On April 6, 2023, the Company received an additional Staff Determination (the “Additional Staff Determination”) from the Staff notifying the Company that, because the Staff did not receive the Company’s Form 10-K for the year ended December 31, 2022, the Company does not comply with Nasdaq’s Listing Rules for continued listing, thus constituting an additional basis for delisting the Company’s securities from The Nasdaq Capital Market. The Additional Staff Determination further notified the Company that the Hearings Panel will consider this matter in their decision regarding the Company’s continued listing on The Nasdaq Capital Market, and that the Company should present its views with respect to this additional deficiency to the Hearings Panel in writing no later than April 13, 2023. On April 13, 2023, the Company filed its response to the Additional Staff Determination.

~~Delaware Court of Chancery Section 205~~

On February 13, 2023, the Company filed a petition under the caption In re Hyzon Motors Inc., C.A. No. 2023-0177-LWW (Del. Ch) in the Delaware Court of Chancery pursuant to Section 205 of the Delaware General Corporation Law (“DGCL”), which permits the Court of Chancery, in its discretion, to validate potentially defective corporate acts due to developments regarding potential interpretations of the DGCL stemming from the Court’s recent decision in Garfield v. Boxed, Inc., 2022 WL 17959766 (Del. Ch. Dec. 27, 2022). On March 6, 2023, the Court of Chancery granted our petition, holding that any defects that may have existed with respect to the conduct of the Special Meeting of Shareholders held on July 15, 2021 to approve the increase in the Company’s authorized share capital were ratified as of the meeting.

~~Table of Contents~~

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis provide information that management believes is relevant to an assessment and understanding of our consolidated results of operations and financial condition. This discussion is intended to supplement, and should be read in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in our ~~2021~~2022 Annual Report filed on Form ~~10-K/A.~~10-K. Unless the context otherwise requires, all references in this section to ~~“Hyzon,” “we,” “us,”~~“Hyzon”, “we”, “us”, and “our” are intended to mean the business and operations of Hyzon Motors Inc. and its consolidated ~~subsidiaries following the consummation of the Business Combination and to Legacy Hyzon and its consolidated subsidiaries prior to the Business Combination.~~subsidiaries.

Overview

Headquartered in Honeoye Falls, New York, with major operations in the United States, the Netherlands, and Australia. ~~Hyzon provides~~We provide decarbonized solutions primarily for the commercial ~~vehicles~~vehicle market and hydrogen supply infrastructure. We are commercializing our proprietary fuel cell technology through assembling and upfitting heavy duty (“HD”) hydrogen fuel cell electric vehicles (“FCEVs”). When we refer to “assembling” or “converting” our FCEVs, we generally mean integrating our fuel cells and fuel cell stacks with batteries, electric motors, and other components into a chassis to form a completed FCEV that we sell. When we “upfit” a vehicle, we generally mean that we provide services to transform a customer's internal combustion engine (“ICE”) vehicle into a FCEV.

Vehicles and Vehicle Platforms

Our commercial vehicle business is focused primarily on assembling and ~~supplying hydrogen-powered fuel cell electric vehicles (“FCEVs”).~~converting FCEVs. Our new strategy takes a focused approach by designing and developing one vehicle platform atin each region to conform with regional regulations and customer preferences. Our strategy to manufacture fuel cells in-house and work with 3rd ~~party~~third-party vehicle assemblers ~~will~~is intended to enable us to maintain an asset-light business model, lower production costs, and ultimately lower ~~Total Cost~~total cost of ~~Ownership~~ownership (“TCO”) for the customer ~~which is~~- a prerequisite for scaling deployments of ~~heavy~~HD and medium duty (“MD”) trucks with customers.

On-road, our potential customers include shipping and logistics companies and retail customers with large distribution networks, such as grocery retailers, food and beverage companies, waste management companies, and municipality and government agencies around the world. Off-road, our potential customers include mining, material handling and port equipment manufacturers and operators. ~~Initial strategic customer groups~~Our initial targeted customers often employ a ~~‘back-to-base’~~“back-to-base” model where their vehicles return to a central base or depot between operations, thereby allowing operators to have fueling independence as the necessary hydrogen can be produced locally at or proximate to the central base and dispensed at optimally-configured hydrogen refueling stations. Hyzon may expand its range of products and hydrogen solutions as the transportation sector increasingly adopts hydrogen propulsion and investments are made in hydrogen production and related infrastructure in accordance with our expectations.

~~In addition, we~~We plan to expand our integration activities across rail, aviation, mobile power and other applications in the future. We expect the opportunities in these sectors to continue to expand with the rapid technological advances in hydrogen fuel cells and the increasing investments in hydrogen production, storage and refueling infrastructure around the world.

Fuel and Infrastructure

Our hydrogen supply infrastructure business is focused on building and fostering a clean hydrogen supply ecosystem with ~~leading~~ partners and third parties from feedstock through hydrogen production, dispensing and financing. We collaborate with strategic partners on development, construction, operation, and ownership of hydrogen production facilities and refueling stations in each major region of our operations, which we intend to complement our back-to-base model and near-term fleet deployment opportunities.

~~Table of Contents~~

Key Trends and Uncertainties

We believe that our performance and future success ~~depend~~depends on several factors that present significant opportunities for us but also pose risks and challenges, including those discussed below and in ~~the section entitled “Risk Factors” included~~Part I, Item 1A. “Risk Factors” in our ~~amended~~ Annual Report filed on Form ~~10-K/A~~10-K for the year ended December 31, ~~2021.~~2022.

Commercial Launch of Hyzon-branded commercial vehicles and other hydrogen solutions

We reported no revenue for the three and nine months ended September 30, 2023. We reported negligible ~~revenue~~ and $2.9 million of revenue from ~~the sale of~~ hydrogen fuel cell ~~systems~~system sales in the United States and FCEVs in China ~~and retrofit services in Europe~~ for the three and nine months ended September 30, 2022, respectively. ~~However, our~~Our business model has yet to be proven. Prior to full commercialization of our commercial vehicle business at scale, we must complete the construction of required manufacturing facilities for our fuel cell components and systems, we must achieve research and development and product development milestones. WeFurthermore, we must establish ~~and~~or invest in companies that will establish or operate facilities capable of producing and testing our hydrogen fuel cell systems and leverage ~~3rd party~~third-party vehicle manufacturers to assemble our hydrogen-powered commercial vehicles in appropriate volumes and at competitive costs.

Until we can generate sufficient additional revenue from our commercial vehicle business, we expect to finance our operations through equity and/or debt financing. The amount and timing of our future funding requirements will depend on many factors, including the pace and results of our development efforts. We expect that any delays in the successful completion of our manufacturing facilities, availability of critical parts, and/or validation and testing will impact our ability to generate ~~revenue.~~revenue and potentially our ability to raise equity and/or debt financing.

Hydrogen Production & Supply Infrastructure

We continue to ~~develop~~explore opportunities for fostering an end-to-end hydrogen ecosystem delivery model, with a partner-driven approach to design, build, own, and operate hydrogen production hubs and downstream dispensing infrastructure expected to provide zero-to-negative carbon intensity hydrogen at below diesel-parity cost structures supporting Hyzon vehicle fleet deployments. We intend to continue forming additional partnerships across the full hydrogen ~~feedstock,~~spectrum with production and dispensing value chain in each major region in which we operate that will be designed to ensure that the hydrogen fuel required is available at the cost and carbon intensity requirements to drive fleet conversions to Hyzon hydrogen FCEVs. Because we have a partner-driven approach, we are naturally reliant upon our partners’ and other industry participants' performance in fulfilling the obligations that we depend on for delivery of each segment of that value chain. Additionally, consistent with other construction projects, there are risks related to realized construction cost and schedule that can impact final cost to produce and deliver hydrogen and timing of that delivery, along with the availability of feedstock near our vehicle fleet deployments. We intend to manage these risks by partnering or collaborating with ~~high quality~~our partners and ~~high performing partners with a track record of timely delivery and instituting commercial agreements~~industry participants to drive down construction cost and achieve on-time scheduled performance.

Continued Investment in Innovation

We believe that we are ~~the~~an industry-leading hydrogen technology company with the most efficient and reliable fuel cell powertrain technologies and ~~an unmatched~~a compelling product and service offering. Our financial performance will be significantly dependent on our ability to maintain this ~~leading~~ position. We expect to incur substantial and increasing research and development expenses as a result. We dedicate significant resources towards research and development, and invest heavily in recruiting talent, especially for vehicle design, vehicle software, fuel cell system, and electric powertrain. We ~~will~~expect to continue to recruit and retain talented personnel to grow our strength in our core technologies. We expect to incur additional stock-based compensation expenses as we support our growth and status as a publicly traded company. We expect our strategic focus on innovation will further solidify our leadership position.

Customer Demand

We are continually seeking to expand our customer base; however, we ~~depend~~are focusing on a few major customers and we expect to follow this ~~will continue~~strategy for the next several years. These customers will mostly employ a back-to-base model in the early adoption phase of FCEVs. ~~Vehicles will return to a central “base” between operations, allowing them to refuel onsite and/or nearby, where hydrogen can be produced locally at or proximate to the central base.~~ While we focus on back-to-base or regional customers, we expect to expand our target customer focus to include longer-haul truck and bus segments, additional vehicle classes, mobile power, and incremental mobility applications (e.g., rail, aviation) for customers around the world.

2521

~~Table of Contents~~

Supplier Relationships

We depend on third parties, including our majority beneficial shareholder and parent company Horizon, for supply of key inputs and components for our products, such as fuel cells and automotive parts. We intend to negotiate potential relationships with industry-leading OEMs to supply chassis for our Hyzon-branded vehicles but do not yet have any binding agreements and there is no guarantee that definitive agreements will be reached. Even if we reach such agreements, such suppliers, including Horizon, may be unable to deliver the inputs and components necessary for us to produce our hydrogen-powered commercial vehicles or hydrogen fuel cell systems at prices, volumes, and specifications acceptable to us. If we are unable to source required inputs and other components from third parties on acceptable terms, it could have a material adverse effect on our business and results of operations.

The automotive industry continues to face ~~many~~ supply chain disruptions. We are experiencing increases in both the cost of and time to receive raw materials, such as semiconductors orand chassis. Any such increase or supply interruptions could materially negatively impact our business, prospects, financial condition and operating results. Many of the parts for our products are sourced from suppliers in China and the manufacturing situation in China remains uncertain.

Market Trends and Competition

The last ten years have seen ~~the rapid~~increased development of alternative energy solutions in the transportation space. We believe this growth will continue to accelerate as increased product offerings, technological developments, reduced costs, additional supporting infrastructure, and increased global focus on climate goals drive broader adoption.

We believe that commercial vehicle operators, one of our initial target markets, will be driven towards hydrogen-powered commercial vehicles ~~predominantly~~not only by the need and desire to decarbonize activities, but also by the potential ~~for~~benefits of lower ~~total cost of ownership~~TCO in comparison to the cost of ownership associated with traditional gasoline and diesel internal combustion engines. Hyzon believes that it has identified a pathway to TCO parity with diesel vehicles with the benefit of subsidies.

Our fuel cell technology can be deployed across a broad range of mobility applications, including on-road, off-road, rail, maritime and aviation.

The competitive landscape for our commercial vehicles ranges from vehicles relying on legacy internal combustion engines, to extended range electric and battery electric engines, to other hydrogen fuel cell and alternative low-to-no carbon emission propulsion vehicles. Competitors include well established vehicle companies already deploying vehicles with internal fuel cell technology and other ~~heavy~~HD vehicle companies that have announced their plans to offer fuel cell trucks in the future. We also face competition from other fuel cell manufacturers. We believe that our company is well positioned to capitalize on growth in the demand for alternative, low-to-no carbon emission propulsion vehicles due to the numerous benefits of hydrogen power, including hydrogen’s abundance, ~~and~~ ability to be produced locally, and the generally faster refueling times for hydrogen-powered commercial vehicles as compared to electricity-powered vehicles. However, in order to successfully execute on our business plan, we must continue to innovate and convert successful research and development efforts into differentiated products, including new commercial vehicle models.

Our current and potential competitors may have greater financial, technical, manufacturing, marketing, and other resources. Our competitors may be able to deploy greater resources to the design, development, manufacturing, distribution, promotion, sales, marketing, and support of their internal combustion, alternative fuel and electric truck programs.

Regulatory Landscape

We operate in a highly regulated industry. The failure to comply with laws or regulations, including but not limited to rules and regulations covering vehicle safety, emissions, dealerships, and distributors, could subject us to significant regulatory risk and changing laws and regulations and changing enforcement policies and priorities could adversely affect our business, prospects, financial condition and operating results. We may also be ~~also~~ required to obtain and comply with the terms and conditions of multiple environmental permits, many of which are difficult and costly to obtain and could be subject to legal challenges. We depend on global customers and suppliers, and adverse changes in governmental policy or trade regimes could significantly impact the competitiveness of our products. Changes to applicable tax laws and regulations or exposure to additional income tax liabilities could affect our business and future profitability. See the section entitled “Government Regulations” in Part I, Item 1. “Business” in our ~~amended~~ Annual Report filed on Form ~~10-K/A~~10-K for the year ended December 31, ~~2021.~~

2022.

2622

~~Table of Contents~~

Results of Operations

The following table sets forth our historical operating results for the periods indicated (in thousands):


		Three Months Ended September 30,								Nine Months Ended September 30,									Three Months Ended September 30,								Nine Months Ended September 30,
		2022		2021		$ Change		% Change		2022		2021		$ Change		% Change			2023		2022		$ Change		% Change		2023		2022		$ Change		% Change
Revenue	Revenue	$	5	$	89	$	(84)	(94)	%	$	2,939	$	89	$	2,850	3202	%	Revenue	$	—	$	5	$	(5)	(100)	%	$	—	$	2,939	$	(2,939)	(100)	%
Operating expense:	Operating expense:																	Operating expense:
Cost of revenue	Cost of revenue	8,203		204		7,999		3921	%	10,226		204		10,022		4913	%	Cost of revenue	3,286		8,203		(4,917)		(60)		6,534		10,226		(3,692)		(36)
Research and development	Research and development	9,241		3,982		5,259		132	%	26,660		8,081		18,579		230	%	Research and development	10,857		9,241		1,616		17		32,794		26,660		6,134		23
Selling, general, and administrative	Selling, general, and administrative	36,103		42,661		(6,558)		(15)	%	75,920		51,607		24,313		47	%	Selling, general, and administrative	21,044		36,103		(15,059)		(42)		100,999		75,920		25,079		33
Restructuring and asset impairment																		Restructuring and asset impairment	4,885		—		4,885		—		4,885		—		4,885		—
Total operating expenses	Total operating expenses	53,547		46,847		6,700		14	%	112,806		59,892		52,914		88	%	Total operating expenses	40,072		53,547		(13,475)		(25)		145,212		112,806		32,406		29
Loss from operations	Loss from operations	(53,542)		(46,758)		(6,784)		15	%	(109,867)		(59,803)		(50,064)		84	%	Loss from operations	(40,072)		(53,542)		13,470		(25)		(145,212)		(109,867)		(35,345)		32
Other income (expense):	Other income (expense):																	Other income (expense):
Change in fair value of private placement warrant liability	Change in fair value of private placement warrant liability	3,447		7,614		(4,167)		(55)	%	13,385		7,614		5,771		76	%	Change in fair value of private placement warrant liability	(240)		3,447		(3,687)		(107)		561		13,385		(12,824)		(96)
Change in fair value of earnout liability	Change in fair value of earnout liability	18,034		73,359		(55,325)		(75)	%	87,371		73,359		14,012		19	%	Change in fair value of earnout liability	(1,307)		18,034		(19,341)		(107)		6,029		87,371		(81,342)		(93)
Gain (loss) on equity securities	Gain (loss) on equity securities	—		—		—		N/M		10,082		—		10,082		N/M		Gain (loss) on equity securities	—		—		—		—		—		10,082		(10,082)		(100)
Foreign currency exchange loss and other income		(3,871)		(116)		(3,755)		3237	%	(6,475)		(175)		(6,300)		3600	%
Interest income (expense), net		279		(254)		533		(210)	%	350		(5,249)		5,599		(107)	%
Foreign currency exchange gain (loss) and other expense, net																		Foreign currency exchange gain (loss) and other expense, net	(3,877)		(4,539)		662		(15)		(2,447)		(7,143)		4,696		(66)
Investment income and interest income, net																		Investment income and interest income, net	1,441		947		494		52		6,501		1,018		5,483		539
Total other income (expense)	Total other income (expense)	17,889		80,603		(62,714)		(78)	%	104,713		75,549		29,164		39	%	Total other income (expense)	(3,983)		17,889		(21,872)		(122)		10,644		104,713		(94,069)		(90)
Net income (loss) before income taxes		(35,653)		33,845		(69,498)		(205)	%	(5,154)		15,746		(20,900)		(133)	%
Loss before income taxes																		Loss before income taxes	$	(44,055)	$	(35,653)	$	(8,402)	24	%	$	(134,568)	$	(5,154)	$	(129,414)	2511	%
Income tax expense	Income tax expense	—		—		—		N/M		526		—		526		N/M		Income tax expense	—		—		—		—		—		526		(526)		(100)
Net income (loss)		$	(35,653)	$	33,845	$	(69,498)	(205)	%	$	(5,680)	$	15,746	$	(21,426)	(136)	%
Net loss																		Net loss	$	(44,055)	$	(35,653)	$	(8,402)	24	%	$	(134,568)	$	(5,680)	$	(128,888)	2269	%
Less: Net loss attributable to noncontrolling interest	Less: Net loss attributable to noncontrolling interest	(10,858)		(776)		(10,082)		1299	%	(16,361)		(1,307)		(15,054)		1152	%	Less: Net loss attributable to noncontrolling interest	(1)		(10,858)		10,857		(100)		(18)		(16,361)		16,343		(100)
Net income (loss) attributable to Hyzon	Net income (loss) attributable to Hyzon	$	(24,795)	$	34,621	$	(59,416)	(172)	%	$	10,681	$	17,053	$	(6,372)	(37)	%	Net income (loss) attributable to Hyzon	$	(44,054)	$	(24,795)	$	(19,259)	78	%	$	(134,550)	$	10,681	(145,231)		(1360)	%

~~Table of Contents~~

Three Months Ended September 30, ~~2022~~2023 and ~~2021~~2022

Revenue. Revenue represents sales of hydrogen FCEVs, fuel cell systems, and upfit services.

We ~~generated negligible~~did not generate revenue for the three months ended September 30, ~~2022 and $0.1 million of revenue from retrofit services performed by Hyzon Europe~~2023. Revenue for the three months ended September 30, ~~2021.~~2022 was negligible, and represents revenue from upfit services in Europe.

Operating Expenses. Operating expenses consist of Cost of revenue, Research and development expenses, Selling, general and administrative expenses, and Restructuring and asset impairment.

Operating expenses for the three months ended September 30, ~~2022~~2023 were ~~$53.5~~$40.1 million compared to ~~$46.8~~$53.5 million for the three months ended September 30, ~~2021. Operating expenses consist of cost of revenue, research and development expenses and selling, general and administrative expenses.~~2022.

Cost of Revenue.Cost of revenue includes direct materials, labor costs, allocated overhead costs related to the ~~manufacturing~~assembly and ~~retrofitting~~upfitting of hydrogen FCEVs, fuel cell systems, estimated warranty costs, and inventory write-downs.

Cost of revenue for the three months ended September 30, 2023 totaled $3.3 million primarily related to cost provisions accrued for customer contract activities and inventory write-downs in Europe. Cost of revenue for the three months ended September 30, 2022 ~~was~~totaled $8.2 million ~~and was $0.2 million for the three months ended September 30, 2021. Cost of revenue for the three months ended September 30, 2022 was~~ primarily related to cost provisions accrued for customer contract activities in Europe, ~~the write-down of~~ inventory write-downs in Europe and the cost of 20 FCEVs delivered to Jiushuang.

Research and Development Expenses. Research and development expenses represent costs incurred to support activities that advance the development of current and next generation ~~hydrogen powered~~hydrogen-powered fuel cell systems, the design and development of electric powertrain, and the integration of those systems into various mobility applications. Our research and development expenses consist primarily of employee-related personnel expenses, prototype materials and tooling, design expenses, consulting and contractor costs and an allocated portion of overhead costs.

Research and development expenses were ~~$9.2~~$10.9 million and ~~$4.0~~$9.2 million for the three months ended September 30, ~~2022~~2023 and ~~2021,~~2022, respectively. The increase was primarily due to ~~$1.9~~$2.1 million in higher personnel costs, which were incurred in order to enhance our research and development expertise in vehicle design, vehicle software, fuel cell ~~system,~~systems, and electric powertrain. The ~~remaining~~ increase was partially offset by a decrease of ~~$3.3~~$0.5 million, ~~is for~~which was primarily related to materials used in research and development to further develop current and next generation hydrogen powered fuel cell systems, to design and develop an electric powertrain, and to integrate those systems into various mobility applications. We expect research and development expenses to continue to increase significantly going forward as we build out our research facilities and organization.development.

Selling, General, and Administrative Expenses.Selling expenses consist primarily of employee-related costs for individuals working in our sales and marketing departments, third-party commissions, and related outreach activities. General and administrative expenses consist primarily of personnel-related expenses associated with our executive, finance, legal, information technology, and human resources functions, as well as professional fees for legal, audit, accounting, and other consulting services, and an allocated portion of overhead costs.

Selling, general, and administrative expenses were ~~$36.1~~$21.0 million and ~~$42.7~~$36.1 million for the three months ended September 30, ~~2022~~2023 and ~~2021,~~2022, respectively. The decrease was primarily due to ~~$26.8~~$9.4 million in lower ~~stock compensation expense. The decrease is offset by an increase of $8.3 million in higher~~ legal, accounting, and consulting fees ~~incurred in connection with~~related to SEC and regulatory investigations and ~~legal matters including~~other litigation and ~~SEC investigation, $1.8~~$0.5 million in ~~higher salary~~lower director and ~~related expenses, and $2.3 million in IT, rent, travel and other office related expenses to support business growth.~~officer (“D&O”) insurance. In addition, we incurred $8.4 million related to the cancellation of the Orten acquisition in ~~Europe.~~Europe in the three months ended September 30, 2022. There was no equivalent cancellation cost for the three months ended September 30, 2023. The decrease was partially offset by an increase of $1.1 million in salary and related expenses, $0.9 million in other expense to support business growth, $0.7 million in stock compensation expense, and $0.5 million in fixed asset write-downs and disposals.

Restructuring and Asset Impairment. Restructuring and asset impairment expenses consist of employee-related charges, asset-related charges and other expenses associated with restructuring activities.

Restructuring and asset impairment expenses were $4.9 million for the three months ended September 30, 2023. The increase was primarily driven by $4.6 million in asset and lease impairments in Europe and $0.3 million in employee-related expenses. We did not have any restructuring and asset impairment for the three months ended September 30, 2022.

Change in Fair Value.Change in fair value represents non-cash gains or losses in estimated fair values of the private placement warrant liability, earnout liability, and investments in equity securities. Private placement warrant and earnout liabilities are remeasured at each balance sheet date. Equity securities are remeasured when there is an observable price adjustment in an orderly transaction for an identical or similar investment in the same investee entity.

Changes in estimated fair values of private placement warrant liability and earnout liability for the three months ended September 30, 2023 were $0.2 million and $1.3 million, respectively. The change in the estimated fair values of the private placement warrant liability and earnout liability were affected by an increase in the Company’s share price for the three months ended September 30, 2023. Changes in estimated fair values of private placement warrant liability, and earnout liability for the three months ended September 30, 2022 were $3.4 million and $18.0 million, respectively. ~~Changes~~The change in the estimated fair values of the private placement warrant liability and earnout liability were affected by a decrease in the Company’s share price for the three months ended September 30, ~~2021 were $7.6 million and $73.4 million, respectively.~~2022.

Foreign Currency Exchange ~~Loss~~Gain (Loss) and Other ~~Expense.~~Expense, net. Foreign currency exchange ~~loss~~gain (loss) represents exchange rate gains and losses related to all transactions denominated in a currency other than our or our subsidiary’s functional currencies.

Foreign currency exchange loss was ~~$3.9~~$3.7 million for the three months ended September 30, ~~2022,~~2023 compared to ~~$0.1~~a loss of $4.5 million in the three months ended September 30, 2022. In addition to the $3.7 million foreign currency exchange loss, there was $0.2 million of other expense.

Investment Income and Interest Income, net. Investment income was $1.0 million and interest income, net was $0.4 million for the three months ended September 30, ~~2021, as there were few transactions in foreign currencies in the prior period.~~

~~Table of Contents~~

~~Interest Income (Expense), net.~~ ~~Interest income was $0.3 million for the three months ended September 30, 2022,~~2023, compared to investment income of $0.6 million and interest ~~expense~~income, net of $0.3 million for the three months ended September 30, ~~2021. Interest expense in the three months ended September 30, 2021,~~2022. Investment income relates ~~primarily~~ to the convertible debt issued in February 2021 and is comprised primarily from changes in the fair value of an embedded derivative associated with the automatic conversion provision of the convertible notes. Upon close of the Business Combination in July 2021, the convertible debt and accrued interest converted into shares of common stock of the Company. There was no debt outstanding during the three months ended September 30, 2022.realized gains on short-term investments.

Income Tax Expense. We had no income tax expense for the three months ended September 30, ~~2022~~2023 and ~~2021.~~2022.

Net Loss Attributable to Noncontrolling Interests. Net loss attributable to noncontrolling interests represents results attributable to third parties in our operating subsidiaries. Net loss is generally allocated based on such ownership interests held by third parties with respect to each of these entities.

Net loss attributable to noncontrolling interests was ~~$10.9 million~~negligible and ~~$0.8~~$10.9 million for the three months ended September 30, ~~2022~~2023 and ~~2021,~~2022, respectively. The ~~change~~decrease is primarily because the Company acquired the remaining equity interests of Hyzon Europe from Holthausen Clean Technology Investments B.V. (“Holthausen”) in ~~the comparative periods is the result of increased activities~~December 2022. The Company now holds 100% ownership in ~~our Netherlands joint venture and the creation of a joint venture in Foshan, China in October 2021.~~Hyzon Europe.

Nine Months Ended September 30, ~~2022~~2023 and ~~2021~~2022

Revenue. We did not generate revenue for the nine months ended September 30, 2023. Revenue for the nine months ended September 30, 2022 was $2.9 million, and represents sales of fuel cell systems in the United States, FCEVs in China, and ~~retrofit~~upfit services in ~~Europe. Revenue for the nine months ended September 30, 2021 was $0.1 million from retrofit services performed by Hyzon~~ Europe.

Operating Expenses. Operating expenses for the nine months ended September 30, ~~2022~~2023 were ~~$112.8~~$145.2 million compared to ~~$59.9~~$112.8 million for the nine months ended September 30, ~~2021. Operating expenses consist of cost of revenue, research and development expenses and selling, general and administrative expenses.~~2022.

Cost of Revenue.Cost of revenue ~~includes direct materials, labor costs, allocated overhead costs~~for the nine months ended September 30, 2023 totaled $6.5 million primarily related to ~~the manufacturing and retrofitting of hydrogen FCEVs, fuel cell systems, estimated warranty costs,~~cost provisions accrued for customer contract activities and inventory ~~write-downs.~~write-downs in Europe. Cost of revenue for the nine months ended September 30, 2022 ~~was~~totaled $10.2 million ~~and was $0.2 million for the nine months ended September 30, 2021. Cost of revenue for the nine months ended September 30, 2022 was~~ primarily related to cost provisions accrued for customer contract activities in Europe, ~~the write-down of~~ inventory write-downs in Europe, and the cost of 20 FCEVs delivered to Jiushuang.

Research and Development Expenses. Research and development expenses ~~represent costs incurred to support activities that advance the development of current~~were $32.8 million and next generation hydrogen powered fuel cell systems, the design and development of electric powertrain, and the integration of those systems into various mobility applications. Our research and development expenses consist primarily of employee-related personnel expenses, prototype materials and tooling, design expenses, consulting and contractor costs and an allocated portion of overhead costs.

~~Research and development expenses were~~ $26.7 million ~~and $8.1 million in~~for the nine months ended September 30, ~~2022~~2023 and ~~2021,~~2022, respectively. The increase was primarily due to ~~$9.1~~$4.7 million in higher personnel costs, which were incurred in order to enhance our research and development expertise in vehicle design, vehicle software, fuel cell ~~system,~~systems, and electric powertrain. The remaining increase of ~~$9.5~~$1.4 million ~~is for~~was primarily related to materials used in research and development to further develop current and next generation hydrogen powered fuel cell systems, to design and develop an electric powertrain, and to integrate those systems into various mobility applications. We expect research and development expenses to continue to increase significantly going forward as we build out our research facilities and organization.development.

Selling, General, and Administrative Expenses. Selling expenses consist primarily of employee-related costs for individuals working in our sales and marketing departments, third-party commissions, and related outreach activities. General and administrative expenses consist primarily of personnel-related expenses associated with our executive, finance, legal, information technology and human resources functions, as well as professional fees for legal, audit, accounting and other consulting services, and an allocated portion of overhead costs.

~~Table of Contents~~

Selling, general, and administrative expenses were $101.0 million and $75.9 million ~~and $51.6 million in~~for the nine months ended September 30, ~~2022~~2023 and ~~2021,~~2022, respectively. The increase was primarily ~~due~~related to ~~$16.5~~$27.0 million in higher legal ~~accounting~~ and ~~consulting~~accounting fees incurred in connection with regulatory and legal matters, including ~~litigation~~the Special Committee investigation, the SEC and regulatory investigations and other litigation. The increase includes a $25.0 million legal loss contingency accrual related to the SEC investigation, ~~$9.4~~of which $8.5 million is recorded as current liabilities and $16.5 million in Accrued SEC settlement. In addition, we incurred $3.9 million in higher salary and related expenses, ~~$5.5~~$3.0 million in higher ~~insurance expense and $7.7 million in IT, rent, travel and other~~ office related expenses to support business ~~growth. In addition, we incurred~~growth, $0.9 million in higher recruitment fees, and $0.3 million in higher stock compensation. The increased expense is partially offset by $8.4 million related to the cancellation of the Orten acquisition in ~~Europe. The increase is offset by $24.6~~Europe that occurred during the nine months ended September 30, 2022 and $1.6 million in lower ~~stock compensation expense. We incurred greater selling, general, and administrative expense~~D&O insurance. There was no equivalent cancellation cost for the nine months ended September 30, ~~2022 as~~2023.

Restructuring and Asset Impairment. Restructuring and asset impairment expenses were $4.9 million for the ~~Company continues to build out its corporate infrastructure, including accounting, audit, legal, regulatory and tax-related services.~~nine months ended September 30, 2023. The increase ~~also resulted from higher director~~was primarily driven by $4.6 million of asset and ~~officer insurance costs, investor~~lease impairments in Europe and ~~public relations costs.~~$0.3 million in employee-related expenses. We did not have any restructuring and asset impairment for the nine months ended September 30, 2022.

Change in Fair Value. ~~Change~~Changes in estimated fair ~~value represents non-cash gains or losses~~values of private placement warrant liability and earnout liability for the nine months ended September 30, 2023 were $0.6 million and $6.0 million, respectively. The change in the estimated fair values of the private placement warrant liability and earnout liability and investments in equity securities. Private placement warrant and earnout liabilities are remeasured at each balance sheet date. Equity securities are remeasured when there is an observable price adjustment in an orderly transaction for an identical or similar investmentwere affected by a decrease in the ~~same investee entity.~~Company’s share price for the nine months ended September 30, 2023. Changes in estimated fair values of private placement warrant liability, earnout liability, and investments in equity securities for the nine months ended September 30, 2022 were $13.4 million, $87.4 million, and $10.1 million, respectively. The change in the estimated fair values of the private placement warrant liability and earnout liability were affected by a decrease in the Company’s share price for the nine months ended September 30, 2022. The $10.1 million increase in the estimated fair value in investments in equity securities in 2022 represents a $12.5 million gain related to our equity investment in Raven SR offset by a $2.4 million impairment of our equity investment in NRG. ~~Change~~There were no equivalent observable price changes or impairments in ~~estimated~~equity securities requiring fair value ~~of private placement warrant and earnout liabilities~~remeasurement for the nine months ended September 30, ~~2021 were $7.6 million and $73.4 million, respectively.~~2023.

Foreign Currency Exchange ~~Loss~~Gain (Loss) and Other ~~Expense.~~Expense, net. Foreign currency exchange loss ~~represents exchange rate gains and losses related to all transactions denominated in a currency other than our or our subsidiary’s functional currencies. Foreign currency exchange loss~~ was ~~$6.5~~$2.1 million for the nine months ended September 30, ~~2022,~~2023 compared to ~~$0.2~~a loss of $7.1 million in the nine months ended September 30, ~~2021, as~~2022. In addition, to the $2.1 million foreign currency exchange loss, there ~~were few transactions in foreign currencies in the prior period.~~was $0.3 million of other expense.

Investment Income and Interest Income, ~~(Expense),~~ net. ~~Interest~~Investment income was ~~$0.4~~$5.6 million ~~in the nine months ended September 30, 2022, compared to~~and interest ~~expense of $5.2~~income, net was $0.9 million in the nine months ended September 30, 2021. Interest expense in the nine months ended September 30, 2021, relates primarily to the convertible debt issued in February 2021 and is comprised primarily from changes in the fair value of an embedded derivative associated with the automatic conversion provision of the convertible notes. Upon close of the Business Combination in July 2021, the convertible debt and accrued interest converted into shares of common stock of the Company. There was no debt outstanding for the nine months ended September 30, 2023, compared to investment income of $0.6 million and interest income, net of $0.4 million for the nine months ended September 30, 2022. Investment income relates to realized gains on short-term investments.

Income Tax Expense. We had no income tax expense for the nine months ended September 30, 2023. For the nine months ended September 30, 2022, the Company recorded a net discrete tax expense of $0.5 million, primarily associated with the establishment of a deferred tax liability that is not expected to offset available deferred tax assets. The Company has cumulative net operating losses at the federal, foreign, and state ~~level~~levels and maintains a full valuation allowance, but for the deferred tax liability described above, against its ~~net~~ deferred tax assets. ~~We had no income tax expense for the nine months ended September 30, 2021.~~

~~Net loss attributable to noncontrolling interests~~ was ~~$16.4 million~~negligible and ~~$1.3~~$16.4 million for the nine months ended September 30, ~~2022~~2023 and ~~2021,~~2022, respectively. The ~~change~~decrease is primarily because the Company acquired the remaining equity interests of Hyzon Europe from Holthausen in ~~the comparative periods is the result of increased activities~~December 2022. The Company now holds 100% ownership in ~~our Netherlands joint venture and the creation of a joint venture in Foshan, China in October 2021.~~

Hyzon Europe.

3023

~~Table of Contents~~

Non-GAAP Financial Measures

In addition to our results determined in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”), we believe the following non-GAAP measures are useful in evaluating our operational performance. We use the following non-GAAP financial information to evaluate our ongoing operations and for internal planning and forecasting purposes. We believe that non-GAAP financial information, when taken collectively, may be helpful to investors in assessing our operating performance.

EBITDA and Adjusted EBITDA

“EBITDA” is defined as net income (loss) before interest income or expense, income tax expense or benefit, and depreciation and amortization. “Adjusted EBITDA” is defined as EBITDA adjusted for stock-based compensation expense, change in fair value of private placement warrant liability, change in fair value of earnout liability, gain (loss) on equity securities and other special items determined by management, if applicable. EBITDA and Adjusted EBITDA are intended as supplemental measures of our performance that are neither required by, nor presented in accordance with, U.S. GAAP. We believe that the use of EBITDA and Adjusted EBITDA provides an additional tool for investors to use in evaluating ongoing operating results and trends and in comparing our financial measures with those of comparable companies, which may present similar non-GAAP financial measures to investors. However, you should be aware that when evaluating EBITDA and Adjusted EBITDA, we may incur future expenses similar to those excluded when calculating these measures. In addition, our presentation of these measures should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items. Our computation of EBITDA and Adjusted EBITDA may not be comparable to other similarly titled measures computed by other companies, because all companies may not ~~calculate~~ calculate in the same fashion.

Because of these limitations, EBITDA and Adjusted EBITDA should not be considered in isolation or as a substitute for performance measures calculated in accordance with U.S. GAAP. We compensate for these limitations by relying primarily on our U.S. GAAP results and using EBITDA and Adjusted EBITDA on a supplemental basis. You should review the reconciliation of net ~~income (loss)~~loss to EBITDA and Adjusted EBITDA below and not rely on any single financial measure to evaluate our business.

The following table reconciles net ~~loss~~income (loss) to EBITDA and Adjusted EBITDA (in thousands):


		Three Months Ended September 30,				Nine Months Ended September 30,					Three Months Ended September 30,				Nine Months Ended September 30,
		2022		2021		2022		2021			2023		2022		2023		2022
Net income (loss)	Net income (loss)	$	(35,653)	$	33,845	$	(5,680)	$	15,746	Net income (loss)	$	(44,055)	$	(35,653)	$	(134,568)	$	(5,680)
Interest (income) expense, net	Interest (income) expense, net	(279)		254		(350)		5,249		Interest (income) expense, net	(419)		(279)		(858)		(350)
Income tax expense	Income tax expense	—		—		526		—		Income tax expense	—		—		—		526
Depreciation and amortization	Depreciation and amortization	839		302		2,445		671		Depreciation and amortization	967		839		3,160		2,445
EBITDA	EBITDA	$	(35,093)	$	34,401	$	(3,059)	$	21,666	EBITDA	$	(43,507)	$	(35,093)	$	(132,266)	$	(3,059)
Adjusted for:	Adjusted for:									Adjusted for:
Change in fair value of private placement warrant liability	Change in fair value of private placement warrant liability	(3,447)		(7,614)		(13,385)		(7,614)		Change in fair value of private placement warrant liability	240		(3,447)		(561)		(13,385)
Change in fair value of earnout liability	Change in fair value of earnout liability	(18,034)		(73,359)		(87,371)		(73,359)		Change in fair value of earnout liability	1,307		(18,034)		(6,029)		(87,371)
Gain (loss) on equity securities		—		—		(10,082)		—
(Gain) loss on equity securities										(Gain) loss on equity securities	—		—		—		(10,082)
Stock-based compensation	Stock-based compensation	1,063		14,766		4,115		15,644		Stock-based compensation	2,156		1,063		5,143		4,115
Executive transition charges (1)	Executive transition charges (1)	517		13,860		517		13,860		Executive transition charges (1)	—		517		—		517
Business combination transaction expenses (2)		—		3,404		—		3,404
Regulatory and legal matters (3)		7,859		111		13,362		111
Orten business combination cancellation		8,440		—		8,440		—
Regulatory and legal matters (2)										Regulatory and legal matters (2)	2,576		7,859		36,212		13,362
Acquisition-related expenses (3)										Acquisition-related expenses (3)	—		8,440		—		8,440
Restructuring and asset impairment										Restructuring and asset impairment	4,885		—		4,885		—

Adjusted EBITDA	Adjusted EBITDA	$	(38,695)	$	(14,431)	$	(87,463)	$	(26,288)	Adjusted EBITDA	$	(32,342)	$	(38,695)	$	(92,616)	$	(87,463)

(1)The 2022 executive transition charges include a separation payment and salary expense for technical advisory services related to the former Executive Chairman. ~~The 2021 executive transition charges include stock-based compensation costs of $13.4 million and salary expense of $0.5 million related to former CTO’s retirement.~~

(2)~~Transaction costs of $3.3 million attributable to the liability classified earnout shares and $0.1 million of write-off of debt issuance costs.~~

~~(3)~~Regulatory and legal matters include legal, advisory, and other professional service fees incurred in connection with the short-seller analyst article from September 2021, and investigations and litigation related thereto.

~~Table of Contents~~

~~Liquidity~~

The ~~Company incurred net loss of $35.7 million and $5.7 million for the three and~~ nine months ended September 30, 2023 includes the legal loss contingency accrual of $25.0 million from the final resolution, subject to court approval, of the SEC investigation.

(3) Acquisition-related expenses incurred for potential and actual acquisitions that are unrelated to the current operations and neither are comparable to the prior period nor predictive of future results. The 2022 ~~respectively. The Company reported~~expenses relate to the Orten business combination cancellation.

Free Cash Flow

In addition to reporting our cash flow generation and usage based upon the operating, investing, and financing classifications included in the unaudited interim Consolidated Statements of Cash Flows, we also report free cash flow, a non-GAAP measure which represents net ~~income of $33.8 million and $15.7 million for the three and nine months ended September 30, 2021, respectively. Net~~ cash used in operating activities ~~was $116.2 million~~less capital expenditures. We believe free cash flow is an important measure of operating performance because it provides management and $52.2 million for the nine months ended September 30, 2022 and 2021, respectively. As of September 30, 2022, we had $70.6 million in cash and cash equivalents, $239.6 million in short-term investments, and positive working capital of $344.2 million. The Business Combination closed on July 16, 2021, generated proceeds of approximately $509.0 millioninvestors with a measure of cash ~~net of transaction costs~~that is available for mandatory payment obligations and ~~redemptions. We believe that~~investment opportunities.

The following table reconciles cash flow used in operating activities to our ~~current~~free cash ~~balance will provide adequate liquidity during the 12-month period from the issuance date of these unaudited interim consolidated financial statements.~~flow (in thousands):


	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Cash flow used in operating activities	$	(30,014)	$	(47,338)	$	(112,072)	$	(116,218)
Less: Capital expenditures	(3,267)		(3,668)		(5,951)		(11,320)
Free cash flow	$	(33,281)	$	(51,006)	$	(118,023)	$	(127,538)

Liquidity and development and commercialization of single heavy duty commercial vehicle platform in each region by leveraging third party contracted manufacturers. Until the Company can generate sufficient revenue from product sales, retrofit services or lease arrangements to cover operating expenses, working capital and capital expenditures, the Company will need to raise additional capital. The Company expects to fund cash needs through a combination of equity and debt financing, including lease securitization, strategic collaborations, and licensing arrangements. If the Company cannot raise additional funds when needed, our financial condition, business, prospects, and results of operations could be materially adversely affected.Going Concern

The Company incurred net losses of $44.1 million and $134.6 million for the three and nine months ended September 30, 2023, respectively. The Company incurred net losses of $35.7 million and $5.7 million for the three and nine months ended September 30, 2022, respectively. Net cash used in operating activities was $112.1 million and $116.2 million for the nine months ended September 30, 2023 and 2022, respectively. As of ~~March~~September 30, 2023, we had $110.6 million in unrestricted cash and cash equivalents, $27.2 million in short-term investments, and positive net working capital of $153.6 million.

In order to reduce the cash used in operating activities, the Company implemented certain cost savings initiatives in late 2022 and the first half of 2023, as well as a restructuring plan in July 2023, as further discussed in Note 4. Restructuring and Related Charges in the unaudited interim consolidated financial statements. While these plans are anticipated to reduce cash outflows when compared to prior periods, the Company’s continued existence is dependent upon its ability to obtain additional financing, as well as to attain and maintain profitable operations by entering into profitable sales or service contracts and generating sufficient cash flow to meet its obligations on a timely basis. The Company’s business will require significant funding to execute its long-term business plans. As of October 31, 2023, unrestricted cash, cash equivalents, and short-term investments were approximately ~~$210~~$129 million.

The Company plans to improve its liquidity through a combination of equity and/or debt financing, alliances or other partnership agreements with entities interested in our technologies, and the liquidation of certain inventory balances. If the Company raises funds in the future by issuing equity securities, dilution to stockholders will occur and may be substantial. Any equity securities issued may also provide for rights, preferences, or privileges senior to those of common stockholders. If the Company raises funds in the future by issuing debt securities, these debt securities could have rights, preferences, and privileges senior to those of common stockholders. The terms of any debt securities or borrowings could impose significant restrictions on the Company’s operations. The capital markets have experienced in the past, and may experience in the future, periods of upheaval that could impact the availability and cost of equity and debt financing. In addition, recent and anticipated future increases in federal fund rates set by the Federal Reserve, which serve as a benchmark for rates on borrowing, will continue to impact the cost of debt financing.

~~Short-Term~~ There can be no assurance that any such financing can be realized by the Company, or if realized, what the terms thereof may be, or that any amount that the Company is able to raise will be adequate to support the Company’s working capital requirements and/or fuel cell technology advancement. If the Company cannot raise additional funds when needed or on acceptable terms, the financial condition, business, prospects, and results of operations could be materially adversely affected. In addition, the Company is subject to, and may become a party to, a variety of litigation, other claims, suits, indemnity demands, regulatory actions, and government investigations and inquiries in the ordinary course of business. As discussed in Note 13. Commitments and Contingencies in the unaudited interim consolidated financial statements, the Company announced a final resolution of the SEC investigation that, if approved by the court, will require the Company to pay a civil penalty of $25.0 million as follows: $8.5 million within 30 days of entry of the final judgment; (2) $8.5 million by December 31, 2024; and (3) $8.0 million within 730 days of entry of the final judgment. The outcome of litigation and

other legal proceedings, including the other claims described under Legal Proceedings in Note 13. Commitments and Contingencies, are inherently uncertain, and adverse judgments or settlements in some or all of these legal disputes may result in materially adverse monetary damages or injunctive relief against us.

Liquidity Requirements

AsOur recent uses of cash have been funding operations and investing in capital expenditures. Our future capital requirements will depend on many factors, including revenue growth rate, achieving profitability on our revenue contracts, the ~~date~~timing and the amount of ~~this filing,~~cash received from customers, capital expenditures associated with our capacity expansion, and the continuing market adoption of our products. Our business will require significant funding to sustain operations and we ~~believe our available liquidity and capital resources~~ will ~~be sufficient to continue~~require significant funding to execute our long-term business strategy over at least the next twelve-month period. This business strategy includes completing the development and commercial launch of our three focus FCEV truck platforms, successfully delivering additional FCEV trucks to customers and expanding our contracted customer pipeline, significantly advancing the commercialization of our 200 kW fuel cell system and manufacturing facility in Bolingbrook, IL, USA including continuing pre-sales of prototype 200 kW fuel cell systems, active management of our cost structure through the detailed cost and cash management plan that has been developed and is already in execution, and strategic hiring of critical personnel to deliver the above mentioned programs.

We have considered and assessed our ability to continue as a going concern for at least the one year from the date of this filing. We have undertaken certain actions to improve our cost structure, cash utilization focus and strategic alignment along with our pathway to cash flow breakeven during the last two quarters of 2022 and the first quarter of 2023:plans.

•Gi~~integrated~~ven the challenging capital market environment that exists today, we implemented certain cost savings initiatives, particularly, in July 2023, the board of directors approved a restructuring program as further discussed in Note 4. Restructuring and Related Charges of the unaudited interim consolidated financial statements. While our ~~organization globally~~plans are anticipated to ~~drive efficiencies in all regions, including reprioritization of hiring plans;~~

•~~eliminated research~~reduce cash outflows when compared to prior periods, our continued existence is dependent upon our ability to obtain additional financing, as well as to attain and ~~development programs deemed not vital to fuel cell and vehicle platform commercialization;~~

•~~significantly reduced the number of vehicle variants in development, focusing on three core vehicle platforms;~~

•halted commercial vehicle deliveries in China and restructured the China operation to align with the revised global strategic and execution priorities, which included a staff reduction of 17 employees;

•~~conducted multiple divestitures to monetize non-core assets or~~maintain profitable operations by entering into profitable sales contracts and ~~acquired 100% ownership of Hyzon Europe~~generating sufficient cash flows to ~~drive further operational efficiencies in~~meet our ~~European operation;~~

~~Table of Contents~~

•~~identified optimizations in our business model that further reduce the working capital requirements for our fuel cell system manufacturing and vehicle assembling business.~~

obligations on a timely basis. However, actual results could vary materially and negatively as a result of a number of factors, ~~including:~~including but not limited to:

•our ability to manage the costs of manufacturing and servicing the ~~FCEV trucks;~~FCEVs;

•revenue received from sales of our ~~FCEV trucks~~FCEVs and ~~200 kW~~200kW single stack fuel cell systems;

•the costs of expanding and maintaining our fuel cell manufacturing facility and equipment;

•our warranty claims ~~experience~~expense should actual warranty claims differ significantly from estimates;

•the scope, progress, results, costs, timing and outcomes of the commercial development of our FCEV ~~truck~~ customer pipeline and conversion to contracts and deliveries;

•the timing and the costs involved in bringing our vehicles and ~~200 kW~~200kW single stack fuel cell systems to market;

•the costs of maintaining, expanding and protecting our intellectual property portfolio, including potential litigation costs and liabilities;

•the timely assembly of, delivery to customers and performance of our ~~FCEV trucks~~FCEVs and ~~200 kW~~200kW single stack fuel cell systems ~~as it relates to receiving~~for purposes of revenue recognition and expanding contracted revenue pipeline with customers;

•the costs of additional general and administrative personnel, including accounting and finance, legal and human resources, as well as costs related to litigation, investigations, or settlements; and

•other risks discussedin our 2022 Annual Report filed on Form 10-K in the section entitled ~~"Risk~~"Risk Factors"."

~~Long-Term Liquidity Requirements~~

Until we can generate sufficient revenue from truck sales and leases and fuel cell sales to cover operating expenses, working capital and capital expenditures, we expect to fund cash needs through a combination of equity and debt financing, including lease securitization, strategic collaborations, and licensing arrangements. If we raise funds by issuing equity securities, dilution to stockholders may result. Any equity securities issued may also provide for rights, preferences or privileges senior to those of holders of our common stock. If we raise funds by issuing debt securities, these debt securities may have rights, preferences and privileges senior to those of holders of our common stock. The terms of debt securities or borrowings could impose significant restrictions on our operations. If we raise funds through collaborations and licensing arrangements, we might be required to relinquish significant rights to our technologies or products, or grant licenses on terms that are not favorable to us. The credit market and financial services industry have in the past, and may in the future, experience periods of upheaval that could impact the availability and cost of equity and debt financing.

While we intend to raise additional capital in the future, if adequate funds are not available, we will need to reevaluate our expansion plans or limit our research and development activities, which could have a material adverse impact on our business prospects.

~~Debt~~

As of September 30, 2022 and December 31, 2022, we have no debt. The convertible notes and accrued interest in the comparative period, were converted to 5,022,052 shares of common stock upon close of the Business Combination.

~~Table of Contents~~

Cash Flows

The following table is summarized from our unaudited interim Consolidated Statements of Cash Flows (in thousands):

Nine Months Ended
September 30,
2022 2021
Net cash used in operating activities $ (116,218) $ (52,242)
Net cash used in investing activities (250,652) (17,635)
Net cash (used in) provided by financing activities (3,944) 554,165


	Nine Months Ended September 30,
	2023		2022
Net cash used in operating activities	$	(112,072)	$	(116,218)
Net cash provided by (used in) investing activities	162,381		(250,652)
Net cash used in financing activities	(371)		(3,944)

Cash Flows for ~~the~~ Nine Months Ended September 30, ~~2022~~2023 and September 30, ~~2021~~2022

Cash Flows from Operating Activities

Net cash used in operating activities was $112.1 million for the nine months ended September 30, 2023, as compared to $116.2 million for the nine months ended September 30, ~~2022, as compared to $52.2 million for the nine months ended September 30, 2021.~~2022. The cash flows used in operating activities for the nine months ended September 30, ~~2022 were~~2023 was primarily driven by a net loss of ~~$5.7~~$134.6 million and adjustments for certain non-cash items and changes in operating assets and liabilities. Non-cash charges and expense primarily consisted of $5.1 million of stock-based compensation expense, $4.9 million in restructuring and asset impairment, $4.8 million for the write-down of inventory, $3.2 million in depreciation and amortization, and $2.1 million in write-down of property and equipment, and $2.1 million in foreign currency transaction loss. Non-cash charges and expense were partially offset by non-cash gain adjustments that consisted of the change in estimated fair value of earnout liability of $6.0 million, accretion of discount on available-for-sale debt securities of $1.5 million, and the change in estimated fair value of the private placement warrant liability of $0.6 million.

Changes in operating assets and liabilities were primarily driven by increases of $16.3 million in other liabilities, $9.4 million in inventory balances, $6.0 million in net related party payables, $3.1 million in contract liabilities, and $0.3 million in accounts receivable and decreases of $9.2 million in accounts payable, $4.1 million in prepaid expenses and other current assets, $2.8 million in accrued liabilities, and $0.3 million in other assets.

Net cash used in operating activities for the nine months ended September 30, 2022 was primarily driven by net loss of $5.7 million adjusted for certain non-cash items and changes in operating assets and liabilities. Non-cash gain adjustments consisted of changes in fair value of the private placement warrant liability of $13.4 million, earnout liability of $87.4 million, and equity securities of $10.1 million. These non-cash gain adjustments were partially offset by $4.1 million stock-based compensation expense and $2.4 million in depreciation and amortization. Changes in operating assets and liabilities were primarily driven by an increase of $16.8 million in inventory balances, an increase in accrued liabilities of $11.7 million, a decrease in accounts receivable of $2.7 million and a decrease of $1.6 million in prepayments for vehicle inventory, other supplier deposits and D&O insurance.

Cash Flows from Investing Activities

Net cash provided by investing activities was $162.4 million for the nine months ended September 30, 2023, as compared to $250.7 million of cash used in ~~operating~~investing activities for the nine months ended September 30, ~~2021 was primarily driven~~2022. The cash flows provided by net income of $15.7 million and adjustments for certain non-cash items and changes in operating assets and liabilities. Non-cash gain adjustments primarily consisted of changes in fair value of the private placement warrant of $7.6 million and earnout liabilities of $73.4 million. These non-cash gain adjustments were partially offset by $29.0 million stock-based compensation expense and $0.7 million in depreciation and amortization. Changes in operating assets and liabilities were primarily driven by $19.6 million in prepayments for vehicle inventory, other supplier deposits and D&O insurance, an increase in accounts receivable of $5.7 million, and $12.0 million in inventory purchases.

~~Cash Flows from Investing Activities~~

~~Net cash used in~~ investing activities ~~was $250.7 million~~ for the nine months ended September 30, ~~2022, as compared~~2023 were primarily driven by $134.9 million of proceeds from maturities of short-term investments and $50.0 million of proceeds from the sale of short-term investments, offset by $16.6 million cash paid to ~~$17.6~~purchase short-term investments and $6.0 million cash paid for ~~the nine months ended September 30, 2021.~~property and equipment. The cash flows used in investing activities for the nine months ended September 30, 2022 were primarily driven by $11.3 million incash paid for property and equipment, ~~purchases,~~ $313.0 million in purchase of short-term investments, offset by $73.7 million in proceeds from maturities of short-term investments.The cash flows used in investing activities for the nine months ended September 30, 2021 were due to $8.8 million in capital expenditures, as well as $4.0 million in machinery and equipment deposits to begin production of hydrogen fuel cell systems and assembly of hydrogen storage systems and $4.8 million of investments in equity securities of NRG and Raven SR. The $8.8 million in capital expenditures were primarily comprised of approximately $2.3 million related to acquiring a facility near Rochester, NY and $4.9 million in machinery equipment.

Cash Flows from Financing Activities

Net cash used in financing activities was $0.4 million for the nine months ended September 30, 2023, as compared to $3.9 million for the nine months ended September 30, ~~2022, as compared to $554.2 million net~~2022. The cash ~~provided by~~flows used in financing activities for the nine months ended September 30, ~~2021.~~2023 were driven primarily by $0.2 million payment towards the finance lease liability and $0.2 million for the net share settlement of equity awards. The cash flows used in financing activities for the nine months ended September 30, 2022 were driven primarily by a $3.1 million payment towards the Horizon IP Agreement. The cash flows provided by financing activities for the nine months ended September 30, 2021 were driven primarily by $509.0 million in proceeds from the Business Combination, net of transaction costs and redemption, and $45.0 million in proceeds from issuance of convertible notes.

~~Table of Contents~~

Contractual Obligations and Commitments

For the nine months ended September 30, ~~2022,~~2023, there were no material changes outside the ordinary course of business within the Contractual Obligations table as previously disclosed in our ~~amended~~ Annual Report filed on Form ~~10-K/A~~10-K for the year ended December 31, ~~2021.~~2022.

Off-Balance Sheet Arrangements

We do not maintain any off-balance sheet arrangements, transactions, obligations or other relationships with unconsolidated entities that would be expected to have a material current or future effect upon our financial condition or results of operations.

Critical Accounting Policies and Estimates

There have been no substantial changes to these estimates, or the policies related to them for the nine months ended September 30, ~~2022.~~2023. For a full discussion of these estimates and policies, see "Critical Accounting Policies and Estimates" in Item 7 of our ~~amended~~ Annual Report filed on Form ~~10-K/A~~10-K for the year ended December 31, ~~2021.~~2022.

Emerging Growth Company Status

Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. Hyzon elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, Hyzon, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard, until such time Hyzon is no longer considered to be an emerging growth company. At times, Hyzon may elect to early adopt a new or revised standard.

In addition, Hyzon intends to rely on the other exemptions and reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an emerging growth company, Hyzon intends to rely on such exemptions, Hyzon is not required to, among other things: (a) provide an auditor’s attestation report on Hyzon’s system of internal control over financial reporting pursuant to Section 404(b) of the Sarbanes-Oxley Act; (b) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act; (c) comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis); and (d) disclose certain executive compensation-related items such as the correlation between executive compensation and performance and comparisons of the Chief Executive Officer’s compensation to median employee compensation.

Hyzon will remain an emerging growth company under the JOBS Act until the earliest of (a) the last day of Hyzon’s first fiscal year following the fifth anniversary of the closing of DCRB’s initial public offering, (b) the last date of Hyzon’s fiscal year in which Hyzon has total annual gross revenue of at least ~~$1.07~~$1.235 billion, (c) the date on which Hyzon is deemed to be a “large accelerated filer” under the rules of the SEC with at least $700.0 million of outstanding securities held by non-affiliates or (d) the date on which Hyzon has issued more than $1.0 billion in non-convertible debt securities during the previous three years.

~~Table of Contents~~

Material Transactions with Related Parties

Horizon ~~Supply~~IP Agreement

Related Party Payables and Receivables

Horizon Fuel Cell Technologies and Related Subsidiaries

In prior periods, the Company made deposit payments to Horizon and its subsidiaries to ~~procure certain~~secure fuel cell components. As of September 30, ~~2022,~~2023, the ~~remaining~~deposit balance ~~is $6.0~~was $4.1 million and i~~ncluded~~included within Prepaid expenses and other current assets in the unaudited interim Consolidated Balance ~~Sheets.~~Sheet. The Company has cancelled certain orders that were previously made against this deposit balance, and the parties are currently in negotiations as to the resolution of this order cancellation matter and the settlement of the deposit balance. The Company has determined that the recovery of this deposit balance represents a contingency. The Company can not estimate the possible loss or range of possible loss, if any, at this time based on the current status of the negotiations.

~~The related party payable to Horizon and its subsidiaries is $0.1 million and $3.7 million as of September 30, 2022 and December 31, 2021, respectively.~~

~~Holthausen and Affiliates~~

As of September 30, ~~2022,~~2023, the related party payable, net to ~~Holthausen~~Horizon and its subsidiaries is $0.1 million. AsThe related party receivable, net from Horizon and its subsidiaries was $6.1 million as of December 31, ~~2021,~~2022. The related party receivable, net at December 31, 2022 primarily relates to the divestiture of Hyzon Motors Technology (Guangdong) Co., Ltd. (“Hyzon Guangdong”), which was subsequently renamed to Guangdong Qingyun Technology Co. Ltd. (“Guangdong Qingyun”). In April 2023, the Company received $6.4 million to settle the related party receivable ~~from Holthausen is $0.3 million.~~

~~Jiushuang Joint Ventures~~

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are a smaller reporting company as defined in Rule 12b-2 under the Exchange Act. As a result, pursuant to Item 305(e) of Regulation S-K, we are not required to provide the information required by this Item.

3627

~~Table of Contents~~

Item 4. Controls and Procedures

(a) Evaluation of Disclosure Controls and Procedures

The term disclosure controls and procedures means controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in company reports filed or submitted under the Exchange Act is accumulated and communicated to management, including our Chief Executive Officer and ~~Interim~~ Chief Financial Officer to allow timely decisions regarding required disclosure.

We do not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent all errors and all instances of fraud due to inherent limitation of internal controls. Because of these inherent limitations there is a risk that material misstatements will not be prevented or detected on a timely basis by internal control over financial reporting. However, these inherent limitations are known features of the financial reporting process. Therefore, it is possible to design into the process safeguards to reduce, though not eliminate, this risk.

Our Chief Executive Officer and ~~Interim~~ Chief Financial Officer have evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), as of September 30, ~~2022.~~2023. Based on such evaluation, our Chief Executive Officer and ~~Interim~~ Chief Financial Officer have concluded that as of September 30, ~~2022~~2023 our disclosure controls and procedures were not effective because of the material weaknesses in internal control over financial reporting described below.

In light of the material weaknesses described below, our management has performed additional analyses, reconciliations, and other post-closing procedures and has concluded that, notwithstanding the ineffectiveness of our disclosure controls and procedures as well as material weaknesses in our internal control over financial reporting as of September 30, ~~2022,~~2023, the unaudited interim consolidated financial statements for the periods covered by and included in this Form 10-Q fairly present, in all material respects, our financial position, results of operations and cash flows as of and for the periods presented in conformity with U.S. GAAP.

(b) Material Weaknesses in Internal Control over Financial Reporting

While preparing the Company’s unaudited interim consolidated financial statements, our management concluded that the following material weaknesses in internal control over financial reporting disclosed in our ~~amended~~ Annual Report filed on Form ~~10-K/A~~10-K for the year ended December 31, ~~2021~~2022 are not fully remediated:

•The Company did not demonstrate a commitment to attract, develop, and retain competent individuals in alignment with objectives and accordingly did not have sufficient qualified resources.

•The Company did not have an effective risk assessment process that successfully identified and assessed risks of material misstatement to ensure controls were designed and implemented to respond to those risks.

•The Company did not have an effective internal information and communication process to ensure that relevant and reliable information was communicated on a timely basis across the organization, to enable financial personnel to effectively carry out their financial reporting and internal control roles and responsibilities.

•The Company did not sufficiently establish structures, reporting lines and appropriate authorities and responsibilities in the pursuit of objectives.

As a consequence, the Company did not effectively design, implement and operate process-level control activities related to revenue recognition, complex accounting transactions, and the financial close process to mitigate risks to an acceptable level.

Because there is a reasonable possibility that material misstatements of the unaudited interim consolidated financial statements will not be prevented or detected on a timely basis, we concluded that these deficiencies represent material weaknesses in our internal control over financial reporting and that our internal control over financial reporting was not effective as of September 30, ~~2022.~~

~~Table of Contents~~

2023.

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material ~~misstatements~~misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. These deficiencies could result in misstatements to our financial statements that would be material and would not be prevented or detected on a timely basis.

With oversight from the Audit Committee and input from the Board of Directors, management has begun designing and implementing changes in processes and controls to remediate the material weaknesses described above. Management and the Board of Directors, including the Audit Committee, are working to remediate the material weaknesses identified herein. While the Company expects to take other remedial actions, actions taken to date include:

•~~appointed~~strengthened the executive management team in a ~~new Chief Executive Officer and Interim~~newly integrated global organization including the appointment of a Chief Financial ~~Officer and created new roles of President of International Operations, President of North America and Chief Operating Officer.~~Officer;

•hired additional finance and accounting personnel over time to augment our accounting staff, including third-party resources with the appropriate technical accounting expertise;

•engaged with external consultants with public company and technical accounting experience to facilitate accurate and timely accounting closes and to accurately prepare and review the ~~unaudited interim~~ consolidated financial statements and related footnote disclosures;

•established a Disclosure Committee and implemented controls and procedures for the disclosure of Company data and information, as well as roles and responsibilities for formal review and sign off process; ~~and~~

•implemented a formal regional general manager consolidated financial statement review and certification process for each SEC ~~filing.~~filing;

•partial implementation of an enterprise resource planning system, the U.S. finance, inventory and procurement modules were implemented during the quarter ended June 30, 2023; and

•established a centralized training function and deployed various training programs globally, including but not limited to global revenue recognition training, SOX awareness training, and 302 certification training.

In addition to the remedial actions taken to date, the Company is taking, or plans to take, the following actions to remediate the material weaknesses identified herein:

•designing and implementing a comprehensive and continuous risk assessment process to identify and assess risks of material misstatements and to ensure that the impacted financial reporting processes and related internal controls are properly designed, maintained, and documented to respond to those risks in our financial reporting;

•further developing and implementing formal policies, processes and documentation procedures relating to financial reporting, including ~~revenue recognition and~~ other complex accounting matters, and consulting with independent accounting experts and advisors;

•formalizing the design of the processes and controls related to sales of our products and services, as well as vendor contracting, fuel cell acceptance, transfer of control of our products to customers, tracking our vehicles' post-sale performance, and archiving documentation in a central system; ~~and~~

•completing ethics training globally and in addition, providing general public company periodic training for Company personnel, including on potential topics such as the responsibilities of a public company, the core values of the Company’s accounting and finance function, and best practices to implement those ~~values.~~values; and

•strengthening IT governance and designing effective IT general controls including program change management, restricting user access to our internal systems used for financial reporting and enhancing the retention of contemporaneous documentation of reviews over IT general controls.

As we work to improve our internal control over financial reporting, we will report regularly to the Company’s Audit Committee on the progress and results of the remediation plan, including the identification, status, and resolution of internal control deficiencies. We may modify our remediation plan and may implement additional measures as we continue to review, optimize and enhance our financial reporting controls and procedures in the ordinary course. We will not be able to fully remediate these material weaknesses until these steps have been completed and have been operating effectively for a sufficient period of time. If we are unable to successfully remediate the material weaknesses, or if in the future, we identify further material weaknesses in our internal control over financial reporting, we may not detect errors on a timely basis and our ~~unaudited interim~~ consolidated financial statements may be materially misstated.

~~Table of Contents~~

(d) Changes in Internal Control over Financial Reporting

~~There have not been any~~Except as described above, with respect to remedial actions taken to date, there were no other changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended September 30, ~~2022,~~2023, that have materially affected, or are reasonably likely to affect, our internal control over financial reporting.

3928

~~Table of Contents~~

PART II – OTHER INFORMATION

Item 1. Legal Proceedings

The information set forth under Note ~~12.~~13. Commitments and Contingencies, to our unaudited interim consolidated financial statements of this ~~quarterly report~~Quarterly Report on Form 10-Q is incorporated by reference in answer to this item. Such information is limited to certain recent developments.

Item 1A. Risk Factors

In addition to the other information discussed in this report, please consider the factors described in Part I, Item 1A., “Risk Factors” in our Annual Report filed on Form 10-K for the year ended December 31, ~~2021, as amended by Amendment No.1 on Form 10-K/A,~~2022 that could materially affect our business, financial condition or future results. There have not been any material changes to the risk factors described in our ~~2021~~2022 Form 10-K, ~~as amended,~~ except ~~for the additional risks~~as noted below, but these are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may adversely affect our business, financial condition or operating results.

~~Adverse developments affecting the financial services industry, including events~~Our management has performed an analysis of our ability to continue as a going concern and has identified substantial doubt about our ability to continue as a going concern. If we are unable to obtain sufficient additional funding or ~~concerns involving liquidity, defaults~~do not have access to capital, we may be required to terminate or ~~non-performance by financial institutions or transactional counterparties, could adversely affect~~significantly curtail our ~~current and projected business operations, financial condition and results of~~ operations.

~~Events involving limited liquidity, defaults, non-performance~~Our management has performed an analysis of our ability to continue as a going concern.Based on their assessment, our management has raised concerns about our ability to continue as a going concern.

Management continues to explore raising additional capital through a combination of debt and/or equity financings to supplement the Company’s capitalization and liquidity. However, as substantial doubt about our ability to continue as a going concern exists, our ability to finance our operations through the sale and issuance of debt or additional equity securities or through bank or other ~~adverse developments~~financing will be challenging and management cannot conclude as of the date of this report that ~~affect~~its plans are probable of being successfully implemented. As of the date of this report, we believe that our financial ~~institutions, transactional counterparties~~resources, existing cash resources and additional sources of liquidity are not sufficient to support planned operations beyond the next 12 months. Our ability to continue as a going concern will depend on our ability to obtain additional capital.

We continue to explore potential sources of financing. However, additional capital may not be available on favorable terms, or at all, and additional equity financing will further dilute our current stockholders. If we raise additional funds by issuing debt securities or preferred stock, or by incurring loans or other ~~companies~~financing, these forms of financing would have rights, preferences, and privileges senior to those of holders of our common stock.

If adequate capital is not available to us in the ~~financial services industry~~amounts needed, we could be required to terminate or ~~the financial services industry generally,~~significantly curtail our operations in which case our investors could lose some or ~~concerns or rumors about any events~~all of these kinds or other similar risks, have in the past and may in the future lead to market-wide liquidity problems. For example, on March 10, 2023, Silicon Valley Bank was closed by the California Department of Financial Protection and Innovation, which appointed the Federal Deposit Insurance Corporation (“FDIC”) as receiver. Similarly, on March 12, 2023, Signature Bank and Silvergate Capital Corp. were each swept into receivership.their investment.

Our available cash and cash equivalents are held in accounts with or managed by financial institutions and consist of cash in our operating accounts and cash and cash equivalents. The amount of cash in our operating accounts exceeds the Federal Deposit Insurance Corporation insurance limits. While we monitor our accounts regularly and adjust our balances as appropriate, the valuation of or our access to these accounts could be negatively impacted if the underlying financial institutions fail or become subject to other adverse conditions in the financial markets. The operations of U.S. and global financial services institutions are interconnectedcorporate restructuring and the ~~performance~~associated headcount reduction may not result in anticipated savings, could result in total costs and ~~financial strength of specific institutions~~expenses that are ~~subject to rapid change, the timing~~greater than expected and ~~extent of which cannot be known. To date, we have experienced no realized losses on, or lack of access to,~~could disrupt our cash held in operating accounts or our invested cash or cash equivalents as a result of adverse conditions in the financial markets or with respect to financial institutions; however, we can provide no assurance that access to our cash held in operating accounts or our invested cash and cash equivalents will not be impacted by such adverse conditions in the future.

Although we assess our banking and customer relationships as we believe necessary or appropriate, our access to funding sources and other credit arrangements in amounts adequate to finance or capitalize our current and projected future business operations could be significantly impaired by factors that affect us, the financial services industry or economy in general. These factors could include, among others, events such as liquidity constraints or failures, the ability to perform obligations under various types of financial, credit or liquidity agreements or arrangements, disruptions or instability in the financial services industry or financial markets, or concerns or negative expectations about the prospects for companies in the financial services industry. These factors could involve financial institutions or financial services industry companies with which we have financial or business relationships but could also include factors involving financial markets or the financial services industry generally.business.

In ~~addition, investor concerns regarding~~July 2023, the ~~U.S. or international financial systems could result in less favorable commercial financing terms,~~Company’s board of directors approved a restructuring plan (the “Restructuring Program”) to improve operational effectiveness and cost reduction, including ~~higher interest rates or costs~~its workforce. Pursuant to the Restructuring Program, the Company expects to rationalize its global footprint, implement a shared service model for procurement and ~~tighter financial~~engineering, and ~~operating covenants, or systemic limitations on access~~transition to ~~credit~~a third-party assembly model for FCEV upfit services. See Note 4. Restructuring and ~~liquidity sources, thereby making it more difficult for us to acquire financing on acceptable terms or at all. Any decline in available funding or access~~Related Charges to our ~~cash~~unaudited interim consolidated financial statements of this Quarterly Report on Form 10-Q for more details on the restructuring.

We may not realize, in full or in part, the anticipated benefits, savings and ~~liquidity resources could, among other risks, adversely impact~~improvements in our ~~ability~~cost structure from our restructuring efforts due to ~~meet~~unforeseen difficulties, delays, or unexpected costs. If we are unable to realize the expected operational efficiencies and cost savings from the restructuring, our operating ~~expenses,~~results and financial ~~obligations or fulfill~~condition would be adversely affected. Furthermore, our ~~other obligations, result~~restructuring plan may be disruptive to our operations. For example, our headcount reductions could yield unanticipated consequences, such as increased difficulties in ~~breaches~~implementing our business strategy, including retention of our ~~contractual obligations or result in violations of federal or state wage~~remaining employees. Employment-related litigation related to the headcount reduction could be costly and ~~hour laws. Any of these impacts, or any other impacts resulting~~prevent management from fully concentrating on the ~~factors described above or other related or similar factors not described above, could have material adverse impacts on our liquidity and our business, financial condition or results of operations.~~business.

4029

~~Table~~

Any future growth would impose significant added responsibilities on members of ~~Contents~~management, including the need to identify, recruit, maintain and integrate additional employees. Due to our limited resources, we may not be able to effectively manage our operations or recruit and retain qualified personnel, which may result in weaknesses in our infrastructure and operations, risks that we may not be able to comply with legal and regulatory requirements, and loss of employees and reduced productivity among remaining employees.

Item 2. Unregistered Sales of Equity Securities, ~~and~~ Use of Proceeds, and Issuer Purchases of Equity Securities

There were no sales of equity securities for the nine months ended September 30, ~~2022~~2023 that were not registered under the Securities Act.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

4130

~~Table of Contents~~

Item 6. Exhibits


Exhibit Number						Description


~~3.1~~						~~Second Amended and Restated Certificate of Incorporation of Hyzon (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the SEC on July 22, 2021)~~

~~3.2~~						~~Amended and Restated Bylaws of Hyzon (incorporated by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K filed with the SEC on July 22, 2021)~~

~~10.1~~10.1#						~~Cancellation~~Employment Agreement, ~~with Orten Holding GmbH,~~ dated ~~September 29, 2022 (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the SEC on~~ as of October ~~5, 2022)~~11 , 2023 between Hyzon Motors Inc. and Stephen W eiland.

31.1						Certification of Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a)

31.2						Certification of ~~Interim~~ Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a)

32.1*						Certification of Chief Executive Officer required by Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. 1350

32.2*						Certification of ~~Interim~~ Chief Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. 1350

101.INS						Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL ~~document.~~document

101.SCH						Inline XBRL Taxonomy Extension Schema Document

101.CAL						Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF						Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB						Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE						Inline XBRL Taxonomy Extension Presentation Linkbase Document

104						Cover Page Interactive Data File (embedded within the Inline XBRL document)

_________________________

* This information is furnished and not filed for purposes of Sections 11 and 12 of the Securities Act of 1933 and Section 18 of the Securities Exchange Act.

# Indicates management contract or compensatory arrangement.

†~~Filed or furnished herewith.~~

4231

~~Table of Contents~~

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


	Hyzon Motors Inc.

Date: ~~May 1,~~November 14, 2023	By:	/s/ Parker Meeks
	Name:	Parker Meeks
	Title:	Chief Executive Officer (Principal Executive Officer)

Date: ~~May 1,~~November 14, 2023	By:	/s/ ~~Jiajia Wu~~Stephen Weiland
	Name:	~~Jiajia Wu~~Stephen Weiland
	Title:	~~Interim~~ Chief Financial Officer (Principal Financial Officer and ~~Chief~~Principal Accounting ~~Officer~~Officer)

4332


		Page No.
PART I – FINANCIAL INFORMATION

Item 1.	Financial Statements(unaudited)	4

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	2420

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	3627

Item 4.	Controls and Procedures	3728

PART II – OTHER INFORMATION		4029

Item 1.	Legal Proceedings	4029

Item 1A.	Risk Factors	4029

Item 2.	Unregistered Sales of Equity Securities ~~and~~ , Use of Proceeds, and Issuer Purchases of Equity Securities	4130

Item 3.	Defaults Upon Senior Securities	4130

Item 4.	Mine Safety Disclosures	4130

Item 5.	Other Information	4130

Item 6.	Exhibits	4231

SIGNATURES		4332